<?xml version="1.0" encoding="UTF-8"?>
<svg height="777.49" width="545.202" xmlns="http://www.w3.org/2000/svg">
 <g id="page" xmlns:svgx="http://www.xml-cml.org/schema/svgx">
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:1.0;" d="M49.610 53.720 L532.910 53.720 "/>
  <g begin="text">
   <text y="49.34" x="49.606,54.606,59.606,64.606" svgx:width="0.5,0.5,0.5,0.28" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;">448 </text>
   <text y="49.34" x="438.646,443.126,447.606,451.146,453.956,458.336,461.466,464.246,468.826,473.206,476.746,480.286,482.166,486.646,491.336,494.116,499.326,501.306,504.086,509.296,514.506,517.286,520.206,524.786,529.996" svgx:width="0.45,0.45,0.35,0.28,0.44,0.31,0.28,0.46,0.44,0.35,0.35,0.19,0.45,0.47,0.28,0.52,0.2,0.28,0.52,0.52,0.28,0.29,0.46,0.52,0.29" style="fill:rgb(0,0,0);font-family:GillSansStd-Italic;font-size:10.0px;stroke:none;">Poster session 2, 20 (s1)</text>
  </g>
  <g begin="text">
   <text y="767.49" x="49.606,57.736,62.426,64.306,67.116,68.996,73.896,75.776,80.156,82.936,87.516,91.366,93.246,97.626,100.756,105.236,108.776,110.656,114.196,116.976,119.376,123.856,128.546,131.676,136.366,141.056" svgx:width="0.81,0.47,0.19,0.28,0.19,0.49,0.19,0.44,0.28,0.46,0.38,0.19,0.44,0.31,0.45,0.35,0.19,0.35,0.28,0.24,0.45,0.47,0.31,0.47,0.47,0.19" style="fill:rgb(0,0,0);font-family:GillSansStd-Italic;font-size:10.0px;stroke:none;">Multiple Sclerosis Journal</text>
   <text y="767.49" x="142.936,145.716,150.716,155.716,160.716,165.716,167.906,170.686,175.686,180.686,182.876,185.656,188.886,193.466,198.466,201.696,204.476,209.476,214.476,219.476,224.476,229.476,234.476" svgx:width="0.28,0.5,0.5,0.5,0.5,0.22,0.28,0.5,0.5,0.22,0.28,0.32,0.46,0.5,0.32,0.28,0.5,0.5,0.5,0.5,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;"> 2014; 20: (S1) 285â€“496</text>
  </g>
  <g begin="text">
   <text y="767.42" x="466.181,473.891,477.741,479.931,482.121,485.971,490.241,494.511,499.301,504.301,509.301,514.201,516.391,520.771,526.291" svgx:width="0.77,0.38,0.22,0.22,0.38,0.43,0.43,0.48,0.5,0.5,0.5,0.22,0.44,0.55,0.77" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;">msj.sagepub.com</text>
  </g>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.25;" d="M49.610 380.300 L77.350 380.300 "/>
  <g begin="text">
   <text y="77.103" x="49.606,52.603,56.599,59.101,62.098,66.598,70.099,74.599,78.595,82.591,85.093,87.595,92.095,96.091,97.603,105.604,110.608,112.12,116.116,120.616,125.116,129.616,132.613,135.115,136.627,139.624,146.122,151.126,152.638,158.641,161.143,163.645,168.145,171.142,175.642,178.639,185.641,189.637,192.139,194.641,198.637,202.138,203.65,210.148,214.144,216.646,220.642,222.154,230.155,234.151,237.148,239.65,242.152,243.664,250.162,255.238,259.738,264.238,266.488,270.988,275.488,279.988,282.985,285.235" svgx:width="0.33,0.44,0.28,0.33,0.5,0.39,0.5,0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.89,0.56,0.25,0.44,0.5,0.5,0.5,0.33,0.28,0.25,0.33,0.72,0.56,0.25,0.67,0.28,0.28,0.5,0.33,0.5,0.33,0.78,0.44,0.28,0.28,0.44,0.39,0.25,0.72,0.44,0.28,0.44,0.25,0.89,0.44,0.33,0.28,0.28,0.25,0.72,0.56,0.5,0.5,0.25,0.5,0.5,0.5,0.33,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">retrospective MS cohort (US Clinformatics Data Mart; N=32,348). </text>
   <text y="88.101" x="49.606,56.104,60.604,64.6,67.597,69.847,73.843,78.343,82.843,85.093,88.594,92.59,97.09,100.087,104.083,108.583,111.085,115.585,119.086,121.588,125.584,130.084,132.334,134.836,139.336,143.332,145.834,150.334,154.33,158.83,162.826,166.822,169.072,172.069,176.065,178.567,182.563,186.064,188.314,194.812,198.808,201.805,205.801,208.051,212.551,216.052,220.048,224.548,226.798,229.3,233.8,236.05,240.55,244.546,247.048,251.044,254.041,261.043,263.545,268.045,272.041,274.291,276.793,281.293,285.289" svgx:width="0.72,0.5,0.44,0.33,0.25,0.44,0.5,0.5,0.25,0.39,0.44,0.5,0.33,0.44,0.5,0.28,0.5,0.39,0.28,0.44,0.5,0.25,0.28,0.5,0.44,0.28,0.5,0.44,0.5,0.44,0.44,0.25,0.33,0.44,0.28,0.44,0.39,0.25,0.72,0.44,0.33,0.44,0.25,0.5,0.39,0.44,0.5,0.25,0.28,0.5,0.25,0.5,0.44,0.28,0.44,0.33,0.78,0.28,0.5,0.44,0.25,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Age- and sex-adjusted incidence rates were used to determine the </text>
   <text y="99.099" x="49.606,53.602,58.102,62.602,66.598,70.594,73.096,77.092,81.592,83.842,84.616,89.116,93.616,100.618,105.118,109.114,112.111,114.361,115.135,119.635,122.632,124.882,125.656,129.652,133.648,137.149,141.145,144.646,146.896,147.67,150.172,154.672,156.922,157.696,160.198,164.698,168.694,170.944,171.718,176.218,180.214,184.21,188.71,193.21,196.207,200.707,205.207,209.707,214.207,216.457,217.231,221.227,225.727,230.227,234.727,237.724,240.226,242.728,244.978,245.752,249.748,254.248,258.748,261.745,264.247,268.747,272.743,277.243,281.239,285.235" svgx:width="0.44,0.5,0.5,0.44,0.44,0.28,0.44,0.5,0.25,0.55,0.5,0.5,0.78,0.5,0.44,0.33,0.25,0.55,0.5,0.33,0.25,0.55,0.44,0.44,0.39,0.44,0.39,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.44,0.44,0.5,0.5,0.33,0.5,0.5,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.5,0.33,0.28,0.28,0.25,0.55,0.44,0.5,0.5,0.33,0.28,0.5,0.44,0.5,0.44,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">expected number of cases in the background cohort; confidence </text>
   <text y="110.097" x="49.606,52.108,56.608,59.11,63.106,66.103,70.603,74.599,77.101,80.602,83.122,86.119,92.122,95.119,98.62,101.617,104.137,106.639,111.139,115.135,117.637,120.157,122.659,127.159,131.155,133.657,138.157,142.657,146.653,149.173,153.673,156.193,159.694,164.194,168.694,173.194,177.19,180.691,183.193,185.713,190.213,194.713,197.233,201.229,205.729,210.229,212.731,215.233,217.735,222.235,226.735,230.731,233.233,235.753,238.75,241.252,244.753,249.253,251.773,256.273,259.27,261.79,268.792,272.788,275.29,277.792,282.292" svgx:width="0.28,0.5,0.28,0.44,0.33,0.5,0.44,0.28,0.39,0.25,0.33,0.67,0.33,0.39,0.33,0.25,0.28,0.5,0.44,0.28,0.25,0.28,0.5,0.44,0.28,0.5,0.5,0.44,0.25,0.5,0.25,0.39,0.5,0.5,0.5,0.44,0.39,0.28,0.25,0.5,0.5,0.25,0.44,0.5,0.5,0.28,0.28,0.28,0.5,0.5,0.44,0.28,0.25,0.33,0.28,0.39,0.5,0.25,0.5,0.33,0.25,0.78,0.44,0.28,0.28,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">intervals (CIs) that include 1 suggest no additional risk of malig-</text>
   <text y="121.095" x="49.606,54.106,58.102,62.602,66.598,71.098,73.348,79.846,82.348,84.85,89.35,91.6,95.596,98.098,102.094,109.096,111.598,116.098,120.094,124.594,131.596,135.592,140.092" svgx:width="0.5,0.44,0.5,0.44,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.44,0.28,0.44,0.78,0.28,0.5,0.44,0.5,0.78,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">nancy with alemtuzumab.</text>
   <text y="132.093" x="49.606,55.924,59.74,63.061,67.885,70.207,73.024,76.345,79.162" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="132.093" x="82.357,87.676,91.996,94.813,99.133,103.453,107.773,112.093,114.343,115.288,117.61,121.93,125.746,127.996,128.941,131.758,134.08,136.897,140.218,142.54,144.79,145.735,150.055,153.871,157.687,160.504,162.754,163.699,168.019,170.836,173.086,174.031,176.353,180.673,184.489,186.739,187.684,193.507,199.825,205.648,210.967,213.784,221.605,226.429,228.679,229.624,233.44,237.76,240.082,243.898,248.218,251.539,253.861,258.181,262.501,264.571,266.821,267.766,272.086,276.406,280.726,285.226" svgx:width="0.61,0.5,0.33,0.5,0.5,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.33,0.28,0.33,0.39,0.28,0.25,0.55,0.5,0.44,0.44,0.33,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.67,0.72,0.67,0.61,0.33,0.89,0.56,0.25,0.55,0.44,0.5,0.28,0.44,0.5,0.39,0.28,0.5,0.5,0.25,0.25,0.55,0.5,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Through the first year of the CARE-MS extension, 1486 </text>
   <text y="143.091" x="49.606,53.926,57.742,60.064,62.386,66.202,70.522,72.844,76.165,78.415,80.629,83.446,87.262,91.078,94.894,97.216,101.536,105.352,109.672,111.922,114.136,117.952,120.274,124.09,130.912,133.234,137.554,141.37,145.69,152.512,156.328,160.648,162.898,165.112,167.434,171.754,174.004,176.218,178.54,182.86,186.676,188.926,191.14,198.961,203.785,206.035,208.249,212.065,214.387,216.709,221.029,223.351,227.167,230.983,233.305,235.555,237.769,240.091,242.908,245.23,249.046,251.368,253.618,255.832,260.152,262.969,267.289,271.609,274.426,278.242,285.244" svgx:width="0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.33,0.44,0.44,0.44,0.28,0.5,0.44,0.5,0.25,0.55,0.44,0.28,0.44,0.78,0.28,0.5,0.44,0.5,0.78,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.89,0.56,0.25,0.55,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.55,0.28,0.33,0.28,0.44,0.28,0.25,0.55,0.5,0.33,0.5,0.5,0.33,0.44,0.78,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">patients received alemtuzumab in the MS clinical trial program </text>
   <text y="154.089" x="49.606,52.423,59.245,63.061,67.381,69.703,73.519,77.839,80.089,81.484,84.301,88.621,90.943,93.265,97.585,103.903,106.72,111.04,115.36,117.61,119.005,123.325,127.645,129.715,134.035,136.285,137.68,144.502,148.822,153.142,155.464,159.784,163.105,165.175,167.425,168.82,173.14,177.46,181.78,186.1,188.35,189.745,194.065,197.881,200.698,204.019,208.339,212.659,215.476,219.796,223.612,227.428,230.245,233.566,236.383,238.705,240.955,242.35,246.67,249.487,251.737,253.132,255.454,259.774,263.59,266.911,270.727,272.797,275.047,276.442,280.762,285.262" svgx:width="0.33,0.78,0.44,0.5,0.28,0.44,0.5,0.25,0.55,0.33,0.5,0.28,0.28,0.5,0.72,0.33,0.5,0.5,0.25,0.55,0.5,0.5,0.25,0.5,0.25,0.55,0.78,0.5,0.5,0.28,0.5,0.39,0.25,0.25,0.55,0.5,0.5,0.5,0.5,0.25,0.55,0.5,0.44,0.33,0.39,0.5,0.5,0.33,0.5,0.44,0.44,0.33,0.39,0.33,0.28,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.5,0.44,0.39,0.44,0.25,0.25,0.55,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(median follow-up 53.4 months, 6483 person-years); of these, 23 </text>
   <text y="165.087" x="49.606,52.423,56.743,58.813,63.133,70.45,73.267,75.184,79.504,83.32,87.64,89.557,93.373,95.29,99.61,101.932,105.748,110.068,114.388,118.708,122.029,125.845,130.165,132.082,138.904,142.72,145.042,147.364,151.684,156.004,159.82,164.14,167.956,171.691,173.761,175.678,181.996,186.316,188.242,195.064,198.88,202.696,207.016,209.338,213.658,217.978,220.795,225.115,227.437,229.354,231.676,235.996,239.812,242.134,246.454,250.27,254.59,258.406,262.222,264.148,266.47,269.287,273.103,277.423,281.743,285.244" svgx:width="0.33,0.5,0.25,0.5,0.83,0.33,0.25,0.5,0.44,0.5,0.25,0.44,0.25,0.5,0.28,0.44,0.5,0.5,0.5,0.39,0.44,0.5,0.25,0.78,0.44,0.28,0.28,0.5,0.5,0.44,0.5,0.44,0.5,0.25,0.25,0.72,0.5,0.25,0.78,0.44,0.44,0.5,0.28,0.5,0.5,0.33,0.5,0.28,0.25,0.28,0.5,0.44,0.28,0.5,0.44,0.5,0.44,0.44,0.25,0.28,0.33,0.44,0.5,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(1.5%) had a diagnosed malignancy. No meaningful incidence trends </text>
   <text y="176.085" x="49.606,55.924,59.74,62.557,66.373,68.623,69.649,72.97,76.786,80.602,84.922,87.172,88.198,92.518,96.838,99.088,100.114,104.434,108.754,115.576,119.896,123.712,126.529,128.779,129.805,134.125,136.942,139.192,140.218,142.54,145.357,149.173,152.989,155.311,162.133,165.949,170.269,172.591,174.841,175.867,179.683,184.003,188.323,191.14,194.461,198.277,201.598,203.668,205.918,206.944,211.264,215.08,218.896,221.713,225.034,227.284,228.31,232.63,235.447,237.697,238.723,241.54,245.86,248.182,250.504,254.824,261.142,263.959,268.279,272.599,274.669,276.919,277.945,282.265,285.262" svgx:width="0.72,0.44,0.33,0.44,0.25,0.55,0.39,0.44,0.44,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.5,0.5,0.78,0.5,0.44,0.33,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.55,0.44,0.5,0.5,0.33,0.39,0.44,0.39,0.25,0.25,0.55,0.5,0.44,0.44,0.33,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.33,0.5,0.28,0.28,0.5,0.72,0.33,0.5,0.5,0.25,0.25,0.55,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">were seen by number of treatment courses, years of follow-up, or </text>
   <text y="187.083" x="49.606,53.422,57.742,64.564,68.884,71.206,75.022,77.344,79.666,83.986,87.802,89.71,93.526,95.848,99.664,106.486,108.808,113.128,116.944,121.264,128.086,131.902,136.222,138.13,142.45,146.77,150.091,153.907,155.815,158.632,162.952,167.272,171.088,173.905,177.721,180.043,182.365,184.273,189.097,191.914,197.737,199.645,203.965,206.035,210.355,214.675,216.997,218.905,223.225,227.545,234.862,236.77,242.593,245.41,247.318,251.638,253.708,258.028,262.348,265.165,269.485,271.555,275.875,280.195,283.012,285.262" svgx:width="0.44,0.5,0.78,0.5,0.28,0.44,0.28,0.28,0.5,0.44,0.25,0.44,0.28,0.44,0.78,0.28,0.5,0.44,0.5,0.78,0.44,0.5,0.25,0.5,0.5,0.39,0.44,0.25,0.33,0.5,0.5,0.44,0.33,0.44,0.28,0.28,0.25,0.56,0.33,0.67,0.25,0.5,0.25,0.5,0.5,0.28,0.25,0.5,0.5,0.83,0.25,0.67,0.33,0.25,0.5,0.25,0.5,0.5,0.33,0.5,0.25,0.5,0.5,0.33,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">cumulative alemtuzumab dose (overall SIR 1.27; 95% CI 0.85-1.92). </text>
   <text y="198.081" x="49.606,54.925,59.245,63.565,66.382,70.702,73.024,77.344,79.972,84.292,88.108,92.428,94.75,97.072,99.394,103.21,106.027,110.347,112.975,116.791,120.607,123.424,127.24,129.562,133.882,138.202,145.024,148.84,151.468,154.285,159.109,161.926,167.749,170.377,174.697,176.767,181.087,185.407,187.729,190.357,194.677,198.997,206.314,208.942,214.765,217.582,220.21,224.53,226.6,230.92,235.24,238.057,242.377,244.447,248.767,253.087,255.904,258.532,264.85,268.666,271.987,274.615,276.937,281.257,285.253" svgx:width="0.61,0.5,0.5,0.33,0.5,0.28,0.5,0.25,0.5,0.44,0.5,0.28,0.28,0.28,0.44,0.33,0.5,0.25,0.44,0.44,0.33,0.44,0.28,0.5,0.5,0.78,0.44,0.25,0.33,0.56,0.33,0.67,0.25,0.5,0.25,0.5,0.5,0.28,0.25,0.5,0.5,0.83,0.25,0.67,0.33,0.25,0.5,0.25,0.5,0.5,0.33,0.5,0.25,0.5,0.5,0.33,0.25,0.72,0.44,0.39,0.25,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Thyroid papillary carcinoma (SIR 1.57; 95% CI 0.70-3.49) was the </text>
   <text y="209.079" x="49.606,56.428,60.748,64.069,66.391,68.677,72.493,76.813,83.635,90.457,94.777,99.097,101.383,108.205,112.021,114.343,116.665,120.985,125.305,129.121,133.441,137.257,141.577,143.899,146.185,150.001,152.323,154.645,156.931,160.747,164.563,167.884,171.7,175.021,177.307,183.625,187.441,190.258,194.074,196.36,198.682,203.002,206.818,209.14,213.46,217.276,221.596,223.918,227.734,230.056,232.342,235.159,237.481,241.801,246.121,248.443,252.763,257.083,260.404,262.69,267.01,271.33,274.147,276.469,280.789,285.289" svgx:width="0.78,0.5,0.39,0.28,0.25,0.44,0.5,0.78,0.78,0.5,0.5,0.25,0.78,0.44,0.28,0.28,0.5,0.5,0.44,0.5,0.44,0.5,0.28,0.25,0.44,0.28,0.28,0.25,0.44,0.44,0.39,0.44,0.39,0.25,0.72,0.44,0.33,0.44,0.25,0.28,0.5,0.44,0.28,0.5,0.44,0.5,0.28,0.44,0.28,0.25,0.33,0.28,0.5,0.5,0.28,0.5,0.5,0.39,0.25,0.5,0.5,0.33,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">most common malignancy; all cases were incidental findings during </text>
   <text y="220.077" x="49.606,53.422,57.742,61.558,63.88,68.2,72.016,74.338,76.66,80.98,85.3,87.91,92.23,95.047,97.657,99.979,102.796,106.612,110.428,112.75,119.572,123.388,127.708,130.03,132.64,136.96,139.777,142.387,146.203,150.523,152.845,157.165,159.487,166.309,173.131,177.451,181.771,185.587,188.197,190.519,194.839,199.159,201.976,206.296,208.618,212.938,215.548,219.868,222.19,225.511,229.831,232.648,236.968,240.784,243.601,246.922,248.992,251.44,256.759,261.079,264.895,267.505,271.825,274.147,278.467,282.283,285.28" svgx:width="0.44,0.5,0.44,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.5,0.33,0.25,0.44,0.5,0.28,0.5,0.28,0.78,0.78,0.5,0.5,0.44,0.25,0.28,0.5,0.5,0.33,0.5,0.28,0.5,0.25,0.5,0.28,0.39,0.5,0.33,0.5,0.44,0.33,0.39,0.25,0.25,0.61,0.5,0.44,0.25,0.5,0.28,0.5,0.44,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">evaluation or treatment of autoimmune thyroid disorders. The other </text>
   <text y="231.075" x="49.606,56.428,60.748,64.069,66.391,69.181,72.997,77.317,84.139,90.961,95.281,99.601,102.391,109.213,113.029,115.351,117.673,121.993,126.313,130.129,134.449,138.265,140.587,144.403,147.724,150.514,156.832,160.648,163.465,167.281,170.071,174.391,177.208,181.024,184.84,188.161,190.483,193.273,197.089,200.905,205.225,209.041,212.857,215.674,218.464,221.281,226.105,228.922,234.745,237.535,241.855,243.925,248.245,252.565,254.887,257.677,261.997,266.317,273.634,276.424,282.247,285.244" svgx:width="0.78,0.5,0.39,0.28,0.25,0.44,0.5,0.78,0.78,0.5,0.5,0.25,0.78,0.44,0.28,0.28,0.5,0.5,0.44,0.5,0.44,0.28,0.44,0.39,0.25,0.72,0.44,0.33,0.44,0.25,0.5,0.33,0.44,0.44,0.39,0.28,0.25,0.44,0.44,0.5,0.44,0.44,0.33,0.25,0.33,0.56,0.33,0.67,0.25,0.5,0.25,0.5,0.5,0.28,0.25,0.5,0.5,0.83,0.25,0.67,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">most common malignancies were breast cancer (SIR 0.85; 95% CI </text>
   <text y="242.073" x="49.606,53.926,55.996,60.316,64.636,67.453,71.773,73.843,78.163,82.483,85.3,87.37,89.719,96.541,100.357,102.679,105.001,109.321,113.641,117.457,121.777,124.099,126.448,133.27,137.086,139.408,143.224,147.544,151.864,158.686,162.502,164.851,167.668,172.492,175.309,181.132,183.481,187.801,189.871,194.191,198.511,200.833,203.182,207.502,211.822,219.139,221.488,227.311,230.128,232.477,236.797,238.867,243.187,247.507,250.324,254.644,256.714,261.034,265.354,268.171,270.241,272.59,276.406,280.726,285.226" svgx:width="0.5,0.25,0.5,0.5,0.33,0.5,0.25,0.5,0.5,0.33,0.25,0.25,0.78,0.44,0.28,0.28,0.5,0.5,0.44,0.5,0.28,0.25,0.78,0.44,0.28,0.44,0.5,0.5,0.78,0.44,0.25,0.33,0.56,0.33,0.67,0.25,0.5,0.25,0.5,0.5,0.28,0.25,0.5,0.5,0.83,0.25,0.67,0.33,0.25,0.5,0.25,0.5,0.5,0.33,0.5,0.25,0.5,0.5,0.33,0.25,0.25,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">0.35-2.04), malignant melanoma (SIR 0.88; 95% CI 0.33-2.35), and </text>
   <text y="253.071" x="49.606,53.422,57.238,60.055,64.375,66.697,70.513,74.329,76.651,78.721,82.537,86.353,89.17,92.986,95.308,99.628,103.948,110.77,114.586,116.656,119.473,124.297,127.114,132.937,135.007,139.327,141.397,145.717,150.037,152.359,154.429,158.749,163.069,170.386,172.456,178.279,181.096,183.166,187.486,189.556,193.876,198.196,201.013,205.333,207.403,211.723,216.043,218.86" svgx:width="0.44,0.44,0.33,0.5,0.28,0.44,0.44,0.28,0.25,0.44,0.44,0.33,0.44,0.28,0.5,0.5,0.78,0.44,0.25,0.33,0.56,0.33,0.67,0.25,0.5,0.25,0.5,0.5,0.28,0.25,0.5,0.5,0.83,0.25,0.67,0.33,0.25,0.5,0.25,0.5,0.5,0.33,0.5,0.25,0.5,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">cervical carcinoma (SIR 1.93; 95% CI 0.48-7.72).</text>
   <text y="264.069" x="49.606,56.104,60.604,65.608,69.604,72.106,77.11,80.611,83.113,87.613,92.617,96.118,99.115" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="264.069" x="101.761,107.26,111.76,115.756,118.402,121.399,123.901,127.402,131.902,134.548,139.048,142.045,144.691,151.693,155.689,158.191,160.693,165.193,169.693,173.689,178.189,182.185,184.687,188.683,192.184,194.83,201.328,203.83,206.332,210.832,213.478,217.474,219.976,223.972,230.974,233.476,237.976,241.972,246.472,253.474,257.47,261.97,264.616,267.118,271.618,274.264,276.766,281.266,285.262" svgx:width="0.61,0.5,0.44,0.25,0.33,0.28,0.39,0.5,0.25,0.5,0.33,0.25,0.78,0.44,0.28,0.28,0.5,0.5,0.44,0.5,0.44,0.28,0.44,0.39,0.25,0.72,0.28,0.28,0.5,0.25,0.44,0.28,0.44,0.78,0.28,0.5,0.44,0.5,0.78,0.44,0.5,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">The risk of malignancies with alemtuzumab in the </text>
   <text y="275.067" x="49.606,57.607,62.611,64.519,68.515,71.017,73.519,78.019,80.521,84.517,88.513,91.015,92.914,95.416,98.413,100.915,104.911,107.413,109.321,113.821,116.818,121.318,125.818,128.815,132.811,139.813,141.712,148.21,152.206,155.707,157.615,162.115,166.615,169.117,171.016,175.516,178.513,182.509,186.505,189.007,193.003,196.0,197.899,200.401,204.901,208.897,213.397,215.305,217.807,222.307,226.303,228.805,230.713,233.215,237.715,239.614,242.116,246.616,250.612,252.52,255.022,259.018,261.853,266.353,270.349,272.257,280.258,285.262" svgx:width="0.89,0.56,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.28,0.33,0.28,0.44,0.28,0.25,0.5,0.33,0.5,0.5,0.33,0.44,0.78,0.25,0.72,0.44,0.39,0.25,0.5,0.5,0.28,0.25,0.5,0.33,0.44,0.44,0.28,0.44,0.33,0.25,0.28,0.5,0.44,0.5,0.25,0.28,0.5,0.44,0.28,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.28,0.44,0.33,0.5,0.44,0.25,0.89,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">MS clinical trial program was not greater than that in the large MS </text>
   <text y="286.065" x="49.606,53.602,58.102,62.602,67.102,70.099,72.601,74.851,77.146,83.149,87.145,89.647,93.643,95.938,100.438,103.435,105.73,108.232,112.732,117.232,120.229,124.729,127.231,131.731,134.026,141.028,145.024,147.526,150.028,154.528,159.028,163.024,167.524,171.52,174.022,178.018,181.519,183.814,190.312,194.308,197.809,200.104,202.606,205.108,209.608,213.604,216.106,220.606,222.901,225.403,229.903,232.9,235.402,239.398,241.9,245.896,250.396,252.691,257.191,261.691,263.986,267.982,271.483,275.479,279.475,282.265" svgx:width="0.44,0.5,0.5,0.5,0.33,0.28,0.25,0.25,0.67,0.44,0.28,0.44,0.25,0.5,0.33,0.25,0.28,0.5,0.5,0.33,0.5,0.28,0.5,0.25,0.78,0.44,0.28,0.28,0.5,0.5,0.44,0.5,0.44,0.28,0.44,0.39,0.25,0.72,0.44,0.39,0.25,0.28,0.28,0.5,0.44,0.28,0.5,0.25,0.28,0.5,0.33,0.28,0.44,0.28,0.44,0.5,0.25,0.5,0.5,0.25,0.44,0.39,0.44,0.44,0.33,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">cohort. Rate of thyroid malignancies was likely inflated by ascer-</text>
   <text y="297.063" x="49.606,52.108,56.104,58.606,63.106,70.108,74.104,78.604,81.106,83.878,88.378,90.88,94.876,98.377,100.627,103.399,109.402,111.904,115.405,119.905,122.677,127.177,130.174,132.946,139.948,143.944,146.446,148.948,153.448,157.948,161.944,166.444,170.44,172.942,176.938,180.439,183.211,189.709,192.211,194.713,197.215,199.987,203.983,208.483,212.983,215.485,217.987,222.487,226.987,230.983,233.755,236.257,240.757,243.529,248.029,252.025,254.797,258.793,262.294,265.795,269.791,273.292,276.793,280.789,285.289" svgx:width="0.28,0.44,0.28,0.5,0.78,0.44,0.5,0.28,0.25,0.5,0.28,0.44,0.39,0.25,0.25,0.67,0.28,0.39,0.5,0.25,0.5,0.33,0.25,0.78,0.44,0.28,0.28,0.5,0.5,0.44,0.5,0.44,0.28,0.44,0.39,0.25,0.72,0.28,0.28,0.28,0.25,0.44,0.5,0.5,0.28,0.28,0.5,0.5,0.44,0.25,0.28,0.5,0.25,0.5,0.44,0.25,0.44,0.39,0.39,0.44,0.39,0.39,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tainment bias. Risk of malignancies will continue to be assessed </text>
   <text y="308.061" x="49.606,52.108,56.608,58.858,61.36,65.86,70.36,74.86,77.857,80.359,84.355,87.352,94.354,96.604,100.105,102.607,107.107,111.607,114.109,118.105,121.606" svgx:width="0.28,0.5,0.25,0.28,0.5,0.5,0.5,0.33,0.28,0.44,0.33,0.78,0.25,0.39,0.28,0.5,0.5,0.28,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">in long-term studies.</text>
   <text y="335.061" x="49.606,55.105,59.605,64.105" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P869</text>
   <text y="346.059" x="49.606,55.609,60.109,65.113,69.613,72.115,75.112,80.116,85.12,87.622,92.626,97.126,99.628,101.878,106.378,111.382,115.882,118.384,122.884,126.385,128.887,132.388,134.638,139.138,142.135,144.385,148.885,153.889,156.886,159.388,161.638,166.138,172.636,179.134,182.131,185.632,189.628,193.624,198.124,201.625,204.622,209.122,212.119,217.123,220.624" svgx:width="0.67,0.5,0.56,0.5,0.28,0.33,0.56,0.56,0.28,0.56,0.5,0.28,0.25,0.5,0.56,0.5,0.28,0.5,0.39,0.28,0.39,0.25,0.5,0.33,0.25,0.5,0.56,0.33,0.28,0.25,0.5,0.72,0.72,0.33,0.39,0.44,0.44,0.5,0.39,0.33,0.5,0.33,0.56,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Longitudinal analysis of anti JCV-serostatus </text>
   <text y="357.057" x="49.606,54.106,59.11,64.114,66.364,70.864,75.868,78.865,81.367,86.371,90.871,95.875,100.375,102.625,105.127,109.123,113.623,117.619,120.121,123.622,125.872,128.869,133.369,137.365,139.615,145.114,153.61,159.613,162.61,166.606,169.108,172.609,177.613,179.863,184.363,187.864,191.365,195.361,198.862,202.363,209.86,213.856,218.86,221.857,224.107,226.609,231.613" svgx:width="0.5,0.56,0.56,0.25,0.5,0.56,0.33,0.28,0.56,0.5,0.56,0.5,0.25,0.28,0.44,0.5,0.44,0.28,0.39,0.25,0.33,0.5,0.44,0.25,0.61,0.94,0.67,0.33,0.44,0.28,0.39,0.56,0.25,0.5,0.39,0.39,0.44,0.39,0.39,0.83,0.44,0.56,0.33,0.25,0.28,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">and antibody levels for PML-risk assessment in </text>
   <text y="368.055" x="49.606,54.61,59.11,62.107,66.607,69.109,71.611,75.607,80.611,88.108,92.608,97.612,100.609,103.606,107.602,111.598,116.098,119.095,123.091,128.095,130.345,138.841,143.845,146.842,151.846,156.346,159.343,161.845,165.841,170.845,173.842" svgx:width="0.56,0.5,0.33,0.5,0.28,0.28,0.44,0.56,0.83,0.5,0.56,0.33,0.33,0.44,0.44,0.5,0.33,0.44,0.56,0.25,0.94,0.56,0.33,0.56,0.5,0.33,0.28,0.44,0.56,0.33,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">natalizumab-treated MS-patients</text>
   <text y="379.053" x="49.606,56.104,58.354,64.357,68.857,72.853" svgx:width="0.72,0.25,0.67,0.5,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">A Chan</text>
   <text y="376.583" x="77.353" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="379.103" x="80.278,82.528,84.778,91.276,97.774,100.024,105.523,108.52,112.516,119.518,124.018" svgx:width="0.25,0.25,0.72,0.72,0.25,0.61,0.33,0.44,0.78,0.5,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, AK Trampe</text>
   <text y="376.583" x="128.013" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="379.103" x="130.938,133.188,135.438,141.936,144.186,149.19,153.186,155.688,162.69,166.686" svgx:width="0.25,0.25,0.72,0.25,0.56,0.44,0.28,0.78,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, A Salmen</text>
   <text y="376.583" x="171.186" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="379.103" x="174.111,176.361,178.611,185.109,187.359,193.857,197.853,202.353,205.854,208.356,212.352,215.349" svgx:width="0.25,0.25,0.72,0.25,0.72,0.44,0.5,0.39,0.28,0.44,0.33,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, G Keusters</text>
   <text y="376.583" x="218.849" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2</text>
   <text y="379.103" x="221.774,224.024,226.274,234.275" svgx:width="0.25,0.25,0.89,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, M </text>
   <text y="390.101" x="49.604,54.608,59.108,63.608,66.605,70.601,77.603,81.599,86.099,90.599,94.595" svgx:width="0.56,0.5,0.5,0.33,0.44,0.78,0.44,0.5,0.5,0.44,0.78" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Subramanyam</text>
   <text y="387.583" x="101.599" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2</text>
   <text y="390.103" x="104.524,106.774,109.024,115.522,117.772,122.776,126.772,130.768" svgx:width="0.25,0.25,0.72,0.25,0.56,0.44,0.44,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, D Paes</text>
   <text y="387.583" x="134.268" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2</text>
   <text y="390.103" x="137.193,139.443,141.693,147.696,149.946,156.444,160.944,163.446" svgx:width="0.25,0.25,0.67,0.25,0.72,0.5,0.28,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, R Gold</text>
   <text y="387.583" x="167.946" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="398.581" x="49.606" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="401.103" x="52.531,58.03,62.53,67.03,70.531,73.528,80.026,84.526,87.028,91.024,95.02,98.521,102.022,104.524,107.026,111.022,113.272,118.771,123.271,127.267,131.767,136.267,142.765,145.015,147.265,153.763,157.759,162.259,164.761,167.011,169.261,173.761,176.263,178.513,184.516,188.512,193.012,196.513,201.013,203.515,208.015,212.515,216.511,218.761,221.011,225.511,228.013,230.263,232.513,236.509,241.009,244.51,248.506,251.008" svgx:width="0.61,0.5,0.5,0.39,0.33,0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25,0.61,0.5,0.44,0.5,0.5,0.72,0.25,0.25,0.72,0.44,0.5,0.28,0.25,0.25,0.5,0.28,0.25,0.67,0.44,0.5,0.39,0.5,0.28,0.5,0.5,0.44,0.25,0.25,0.5,0.28,0.25,0.25,0.44,0.5,0.39,0.44,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Ruhr-University Bochum, Dept. of Neurology, St. Josef-</text>
   <text y="412.101" x="49.606,56.104,60.604,64.105,68.605,71.107,73.609,78.109,80.611,82.861,85.111,90.61,95.11,99.106,103.606,108.106,114.604,116.854,119.104,125.602,129.598,133.099,139.597,144.097,148.597,152.593,154.843" svgx:width="0.72,0.5,0.39,0.5,0.28,0.28,0.5,0.28,0.25,0.25,0.61,0.5,0.44,0.5,0.5,0.72,0.25,0.25,0.72,0.44,0.39,0.72,0.5,0.5,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Hospital, Bochum, Germany, </text>
   <text y="409.583" x="157.092" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">2</text>
   <text y="412.103" x="160.017,165.516,168.018,172.518,177.018,181.014,185.514,187.764,190.761,195.261,199.257,203.253,205.503,207.753,213.756,218.256,224.754,229.254,232.755,235.257,239.757,244.257,248.253,250.503,252.753,260.25,265.749,267.999" svgx:width="0.61,0.28,0.5,0.5,0.44,0.5,0.25,0.33,0.5,0.44,0.44,0.25,0.25,0.67,0.5,0.72,0.5,0.39,0.28,0.5,0.5,0.44,0.25,0.25,0.83,0.61,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Biogen Idec, Cambridge, MA, </text>
   <text y="423.101" x="49.605,56.103,60.603,63.105,65.607,69.603,74.103,76.353,80.853,83.355,87.855,90.357,94.353" svgx:width="0.72,0.5,0.28,0.28,0.44,0.5,0.25,0.5,0.28,0.5,0.28,0.44,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">United States</text>
   <text y="450.101" x="49.605,55.608,60.108,64.104,69.108,73.608,77.442,81.942,86.946,91.95,96.954,99.951" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="450.101" x="105.063,110.067,114.063,117.06,121.56,125.061,127.563,131.559,134.061,138.561,142.062,144.312,147.174,151.674,154.671,156.921,159.783,163.779,168.279,170.781,173.283,176.28,179.781,185.784,191.454,194.451,198.447,202.947,205.449,207.951,212.451,216.951,221.451,223.953,227.949,231.45,233.7,236.562,240.063,244.059,247.056,251.556,255.552,259.053,261.303,264.165,268.161,271.662,273.912,276.774,280.77,285.27" svgx:width="0.56,0.44,0.33,0.5,0.39,0.28,0.44,0.28,0.5,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.44,0.5,0.28,0.28,0.33,0.39,0.67,0.72,0.33,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.28,0.44,0.39,0.25,0.55,0.39,0.44,0.33,0.5,0.44,0.39,0.25,0.55,0.44,0.39,0.25,0.55,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Serostatus of anti-JCV-antibodies serves as an </text>
   <text y="461.099" x="49.605,53.601,57.102,59.604,63.6,68.1,70.602,73.104,76.605,81.105,85.101,89.601,92.346,95.343,97.845,101.346,105.846,108.591,113.091,116.088,120.084,124.584,127.086,131.082,133.584,138.084,141.081,143.817,146.814,151.314,154.311,157.056,161.556,165.552,168.054,172.05,174.552,177.054,181.05,185.55,192.552,196.548,201.048,204.045,208.041,211.542,215.043,219.543,223.539,226.041,230.037,232.539,236.535,241.035,243.771,248.271,251.268,255.768,260.268,263.265,267.261,270.762,274.263,276.765,281.265,285.261" svgx:width="0.44,0.39,0.28,0.44,0.5,0.28,0.28,0.39,0.5,0.44,0.5,0.25,0.33,0.28,0.39,0.5,0.25,0.5,0.33,0.44,0.5,0.28,0.44,0.28,0.5,0.33,0.25,0.33,0.5,0.33,0.25,0.5,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.33,0.44,0.39,0.39,0.5,0.44,0.28,0.44,0.28,0.44,0.5,0.25,0.5,0.33,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">established risk predictor for natalizumab-associated progressive </text>
   <text y="472.097" x="49.605,56.607,61.107,63.609,66.111,68.613,71.61,76.11,80.106,84.102,86.604,89.403,91.905,95.901,100.401,104.901,109.401,113.397,117.897,121.893,125.889,130.389,134.889,138.885,141.387,145.887,150.387,154.383,156.885,161.385,165.885,168.684,171.681,176.685,184.686,190.185,193.182,195.432,198.231,206.232,210.732,213.729,217.725,220.524,223.521,227.517,231.513,235.509,240.009,242.511,245.013,248.928,251.178,253.977,256.479,260.979,264.975,267.774,270.276,274.272,278.772,282.768,285.27" svgx:width="0.78,0.5,0.28,0.28,0.28,0.33,0.5,0.44,0.44,0.28,0.25,0.28,0.44,0.5,0.5,0.5,0.44,0.5,0.44,0.44,0.5,0.5,0.44,0.28,0.5,0.5,0.44,0.28,0.5,0.5,0.25,0.33,0.56,0.89,0.61,0.33,0.25,0.25,0.89,0.5,0.33,0.44,0.25,0.33,0.44,0.44,0.44,0.5,0.28,0.28,0.5,0.25,0.25,0.28,0.5,0.44,0.25,0.28,0.44,0.5,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">multifocal leukoencephalopathy (PML). More recently, the level </text>
   <text y="483.095" x="49.605,54.105,57.102,59.352,60.936,64.932,69.432,71.934,74.436,78.936,83.436,87.936,90.438,94.434,97.935,100.185,101.769,104.766,107.268,111.768,116.268,120.264,124.764,127.761,130.011,131.595,135.591,139.092,141.342,142.926,147.426,151.422,153.924,157.92,160.917,167.919,170.421,174.921,178.917,183.417,185.667,187.251,191.751,195.252,197.754,202.254,206.754,209.004,210.588,214.584,216.834,218.418,221.919,225.915,229.911,234.411,238.911,243.411,245.661,247.245,251.745,255.741,260.241,264.237,267.234,271.23,273.732,276.234,280.734,285.234" svgx:width="0.5,0.33,0.25,0.55,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.28,0.44,0.39,0.25,0.55,0.33,0.28,0.5,0.5,0.44,0.5,0.33,0.25,0.55,0.44,0.39,0.25,0.55,0.5,0.44,0.28,0.44,0.33,0.78,0.28,0.5,0.44,0.5,0.25,0.55,0.5,0.39,0.28,0.5,0.5,0.25,0.55,0.44,0.25,0.55,0.39,0.44,0.44,0.5,0.5,0.5,0.25,0.55,0.5,0.44,0.5,0.44,0.33,0.44,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">of antibodies (index) as determined using a second generation </text>
   <text y="494.093" x="49.605,53.601,58.101,60.603,63.105,66.102,69.603,75.606,81.276,84.273,89.772,95.271,98.268,103.272,109.275,111.777,116.277,120.273,123.774,126.276,130.272,132.774,136.275,140.775,143.277,147.777,151.773,155.769,160.269,162.771,167.271,170.268,174.768,179.268,183.768,187.269,191.265,195.765,198.267,200.769,205.269,207.771,210.768,215.268,218.265,220.767,225.267,229.263,232.26,234.762,237.759,241.755,244.752,247.254,251.754,255.75,258.252,260.754,265.254,269.25,271.752,274.749,277.251,280.752,285.252" svgx:width="0.44,0.5,0.28,0.28,0.33,0.39,0.67,0.72,0.33,0.61,0.61,0.33,0.56,0.72,0.25,0.5,0.44,0.39,0.25,0.44,0.28,0.39,0.5,0.25,0.5,0.44,0.44,0.5,0.25,0.5,0.33,0.5,0.5,0.5,0.39,0.44,0.5,0.25,0.28,0.5,0.25,0.33,0.5,0.33,0.28,0.5,0.44,0.33,0.25,0.33,0.44,0.33,0.28,0.5,0.44,0.25,0.28,0.5,0.44,0.25,0.33,0.28,0.39,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">anti-JCV-ELISA has also been proposed to further refine the risk </text>
   <text y="505.091" x="49.605,52.107,56.607,58.857,63.357,67.353,71.853,75.849,78.351,82.851,87.351,89.601,94.605,102.606,108.105" svgx:width="0.28,0.5,0.25,0.5,0.44,0.5,0.44,0.28,0.5,0.5,0.25,0.56,0.89,0.61,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">to develop PML.</text>
   <text y="516.089" x="49.605,56.607,61.611,64.608,68.604,72.6,75.597,78.099,82.599,86.595,90.096" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives:</text>
   <text y="533.09" x="61.602,65.598,68.595,70.845,73.599,78.468,82.968,85.218,87.468,91.464,95.964,99.96,106.962,109.464,113.964,117.96,120.21,122.46,124.962,129.462,133.458,135.708,137.949,141.945,145.446,148.947,153.447,157.443,159.945,163.941,166.443,168.945,173.445,177.945,180.195,182.436,186.936,190.932,193.434,199.932,203.928,207.924,212.424,214.674,216.915,220.911,225.411,227.913,230.415,233.412,236.913,242.916,249.252,251.502,253.752,257.748,262.248,264.75,267.252,271.752,276.252,280.752,285.252" svgx:width="0.44,0.33,0.25,0.55,0.61,0.5,0.25,0.55,0.44,0.5,0.44,0.78,0.28,0.5,0.44,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.44,0.39,0.39,0.5,0.44,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.44,0.28,0.72,0.44,0.44,0.5,0.25,0.55,0.44,0.5,0.28,0.28,0.33,0.39,0.67,0.72,0.25,0.55,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">a) To examine the association between anti-JCV antibody </text>
   <text y="544.088" x="73.599,76.101,80.601,85.101,89.097,93.597,95.847,97.377,101.373,105.873,110.373,112.623,114.153,119.157,127.158,132.324,134.574,136.104,139.101,141.603,145.104,149.604,151.854,153.384,155.886,160.386,162.636,164.166,168.162,172.662,174.912,176.442,178.944,183.444,187.944,191.94,196.44,200.436,204.936,209.436,213.432,217.932,220.434,222.684,224.214,228.21,232.71,237.21,241.71,244.707,247.209,249.459,250.989,255.489,258.486,260.736,262.266,266.766,270.762,273.264,277.26,279.762,282.264" svgx:width="0.28,0.5,0.5,0.44,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.56,0.89,0.61,0.25,0.55,0.33,0.28,0.39,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.44,0.5,0.25,0.55,0.28,0.5,0.5,0.44,0.5,0.44,0.5,0.5,0.44,0.5,0.28,0.25,0.55,0.44,0.5,0.5,0.5,0.33,0.28,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.44,0.28,0.44,0.28,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">index and PML risk in an independent cohort of natali-</text>
   <text y="555.086" x="73.599,77.595,82.095,89.097,93.093,97.593,100.59,103.092,106.089,110.085,114.081,116.583,120.579,125.079,127.329,131.829,135.825,138.327,140.829,144.825,149.325,151.827,155.328" svgx:width="0.44,0.5,0.78,0.44,0.5,0.33,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">zumab-treated patients;</text>
   <text y="566.084" x="61.602,66.102,69.099,71.349,73.599,76.101,80.601,82.563,86.559,90.06,93.561,97.557,101.058,104.559,106.521,111.021,114.018,118.518,123.018,127.518,130.515,133.017,135.519,140.019,144.519,146.481,150.981,153.978,155.94,160.44,164.436,166.938,169.44,173.436,177.936,180.438,183.939,185.901,192.399,194.901,197.403,201.903,203.865,207.366,211.362,214.359,218.859,222.36,224.862,228.858,231.36,235.86,239.361,241.323,245.319,249.819,253.815,258.315,262.815,266.811,270.312,272.274,276.27,280.77,285.27" svgx:width="0.5,0.33,0.25,0.55,0.28,0.5,0.25,0.44,0.39,0.39,0.44,0.39,0.39,0.25,0.5,0.33,0.5,0.5,0.5,0.33,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.28,0.28,0.5,0.25,0.39,0.44,0.33,0.5,0.39,0.28,0.44,0.28,0.5,0.39,0.25,0.44,0.5,0.44,0.5,0.5,0.44,0.39,0.25,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">b) to assess proportion of patients with serostatus changes and </text>
   <text y="577.082" x="73.599,76.101,80.601,85.101,89.601,92.103,94.605,99.105,103.605,106.107,110.607,114.603,117.105,119.355,122.856,125.358,129.354,133.854,136.356,138.858,141.36,143.862,148.362,150.612,155.112,158.109,160.359,164.355,168.855,171.357,173.859,176.856,180.357,186.36,192.03,195.027,197.529,202.029,206.529,210.525,215.025" svgx:width="0.28,0.5,0.5,0.5,0.28,0.28,0.5,0.5,0.28,0.5,0.44,0.28,0.25,0.39,0.28,0.44,0.5,0.28,0.28,0.28,0.28,0.5,0.25,0.5,0.33,0.25,0.44,0.5,0.28,0.28,0.33,0.39,0.67,0.72,0.33,0.28,0.5,0.5,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">longitudinal stability of anti-JCV-index.</text>
   <text y="594.083" x="49.596,58.092,62.088,65.085,70.089,74.589,79.593,83.094,86.091" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="594.083" x="88.296,92.796,95.046,99.546,104.046,108.546,110.751,115.251,117.753,122.253,126.753,131.253,133.458,136.959,140.955,147.957,152.457,154.959,158.955,162.456,164.661,167.658,170.655,175.155,182.157,184.362,188.862,193.362,197.862,200.067,202.569,207.069,211.569,216.069,218.571,221.073,225.573,230.073,232.575,237.075,241.071,243.573,246.075,250.575,252.78,257.28,261.78,265.281,269.277,272.274,276.774,280.77,285.27" svgx:width="0.5,0.25,0.5,0.5,0.5,0.25,0.5,0.28,0.5,0.5,0.5,0.25,0.39,0.44,0.78,0.5,0.28,0.44,0.39,0.25,0.33,0.33,0.5,0.78,0.25,0.5,0.5,0.5,0.25,0.28,0.5,0.5,0.5,0.28,0.28,0.5,0.5,0.28,0.5,0.44,0.28,0.28,0.5,0.25,0.5,0.5,0.39,0.44,0.33,0.5,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">1,009 blood samples from 471 longitudinally observed </text>
   <text y="605.081" x="49.596,54.096,58.092,60.594,63.096,67.092,71.592,74.094,77.595,79.845,81.429,87.927,91.923,94.92,98.916,101.166,102.75,106.746,111.246,113.748,116.25,120.246,124.242,126.744,130.74,135.24,137.49,139.074,143.574,147.57,150.072,152.574,157.074,161.574,168.072,170.574,175.074,179.07,181.32,182.904,185.901,190.401,193.398,195.648,197.232,200.229,204.729,209.229,211.731,214.233,218.733,222.729,224.979,226.563,229.065,233.061,236.562,239.064,241.566,246.066,250.566,252.816,254.4,257.397,261.897,264.894,267.144,268.728,272.724,277.224,279.726,282.228" svgx:width="0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.44,0.5,0.28,0.28,0.44,0.44,0.28,0.44,0.5,0.25,0.55,0.5,0.44,0.28,0.28,0.5,0.5,0.72,0.28,0.5,0.44,0.25,0.55,0.33,0.5,0.33,0.25,0.55,0.33,0.5,0.5,0.28,0.28,0.5,0.44,0.25,0.55,0.28,0.44,0.39,0.28,0.28,0.5,0.5,0.25,0.55,0.33,0.5,0.33,0.25,0.55,0.44,0.5,0.28,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">patients were collected nationwide for routine testing for anti-</text>
   <text y="616.079" x="49.596,54.096,58.092,60.594,64.59,67.092,69.594,73.59,78.09,85.092,89.088,93.588,95.613,99.609,104.109,106.611,109.113,113.613,118.113,122.613,125.115,129.111,132.612,134.637,139.137,143.637,146.634,149.136,153.636,158.136,160.161,164.661,169.161,173.157,177.657,179.682,182.184,186.18,190.68,194.676,197.178,199.203,201.705,204.702,208.698,212.694,215.196,222.198,226.194,230.694,233.196,235.221,239.721,243.717,246.219,252.717,256.713,260.709,265.209,267.234,271.734,276.234,280.734,285.234" svgx:width="0.5,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.25,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.28,0.44,0.39,0.25,0.5,0.5,0.33,0.28,0.5,0.5,0.25,0.5,0.5,0.44,0.5,0.25,0.28,0.44,0.5,0.44,0.28,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.5,0.44,0.28,0.72,0.44,0.44,0.5,0.25,0.5,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">natalizumab antibodies during open label treatment between 2007 </text>
   <text y="627.077" x="49.596,53.592,58.092,62.592,64.842,66.066,70.566,75.066,79.566,84.066,86.316,88.566,89.79,94.794,97.791,102.291,109.293,111.543,112.767,117.267,119.517,120.741,125.241,128.238,130.488,131.712,136.212,138.462,139.686,144.186,148.182,150.684,153.186,157.182,161.682,164.184,167.685,169.935,171.159,177.657,182.157,186.657,188.907,190.131,192.633,196.629,199.131,203.127,206.124,208.374,209.598,214.098,218.094,222.594,226.59,229.092,233.592,238.092,242.088,246.588,248.838,250.062,255.066,263.067,268.233,270.483,271.707,274.209,280.707,285.207" svgx:width="0.44,0.5,0.5,0.25,0.55,0.5,0.5,0.5,0.5,0.25,0.25,0.55,0.56,0.33,0.5,0.78,0.25,0.55,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.72,0.5,0.5,0.25,0.55,0.28,0.44,0.28,0.44,0.33,0.25,0.55,0.5,0.44,0.5,0.44,0.28,0.5,0.5,0.44,0.5,0.25,0.55,0.56,0.89,0.61,0.25,0.55,0.28,0.72,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">and 2010. From 3 of 6 patients who later developed PML two </text>
   <text y="638.075" x="49.596,53.097,57.093,64.095,68.595,71.097,75.093,78.594,81.177,85.173,89.169,93.165,97.665,100.248,106.746,110.742,113.739,117.735,120.318,124.314,128.814,132.81,135.312,137.814,141.81,146.31,148.812,152.808,155.391,159.891,164.391,166.641,171.141,174.138,178.638,183.138,185.388,189.888,192.471,199.473,203.973,208.473,210.975,215.475,218.976,221.559,226.059,229.056,231.558,236.058,239.055,241.638,244.14,248.64,251.223,255.723,258.225,262.221,266.721,271.221,275.721,279.222,281.724,285.225" svgx:width="0.39,0.44,0.78,0.5,0.28,0.44,0.39,0.25,0.44,0.44,0.44,0.5,0.25,0.72,0.44,0.33,0.44,0.25,0.44,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.44,0.25,0.5,0.5,0.25,0.5,0.33,0.5,0.5,0.25,0.5,0.25,0.78,0.5,0.5,0.28,0.5,0.39,0.25,0.5,0.33,0.28,0.5,0.33,0.25,0.28,0.5,0.25,0.5,0.28,0.44,0.5,0.5,0.5,0.39,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">samples each were available 24.5-35.3 months prior to diagnosis </text>
   <text y="649.073" x="49.596,52.593,57.093,60.09,64.086,67.083,72.087,80.088,85.254,87.504,89.889,93.39,97.386,104.388,108.888,111.39,115.386,118.887,121.137,123.387,125.772,130.272,134.772,137.022,139.407,143.907,146.904,149.406,153.906,156.903,159.153,161.538,164.04,171.042,178.044,182.544,187.044,191.544,195.045,199.545,204.045,208.545,211.542,215.538,219.039,222.54,225.042,229.542,234.042,237.039,239.289,241.539,243.762,248.631,252.627,256.128,258.63,261.132,265.632,270.132,272.382,274.767,277.764,282.264,285.261" svgx:width="0.33,0.5,0.33,0.44,0.33,0.56,0.89,0.61,0.25,0.55,0.39,0.44,0.78,0.5,0.28,0.44,0.39,0.25,0.25,0.55,0.5,0.5,0.25,0.55,0.5,0.33,0.28,0.5,0.33,0.25,0.55,0.28,0.78,0.78,0.5,0.5,0.5,0.39,0.5,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.33,0.25,0.25,0.55,0.61,0.44,0.39,0.28,0.28,0.5,0.5,0.25,0.55,0.33,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(pre-PML samples, no prior immunosuppression). Testing for </text>
   <text y="660.071" x="49.596,53.592,58.092,60.594,63.096,66.093,69.594,75.597,81.933,84.138,88.134,92.634,95.136,97.638,102.138,106.638,111.138,113.64,117.636,121.137,123.342,129.84,133.836,137.337,139.542,144.042,148.038,151.035,154.032,158.532,161.529,168.531,172.527,177.027,179.232,181.734,186.234,188.439,192.435,194.64,199.14,201.642,204.144,208.644,213.144,217.14,221.64,223.845,226.842,230.838,234.339,238.839,241.341,245.841,250.341,252.546,257.046,260.547,263.049,267.549,272.049,274.254,276.756,281.256,285.252" svgx:width="0.44,0.5,0.28,0.28,0.33,0.39,0.67,0.72,0.25,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.28,0.44,0.39,0.25,0.72,0.44,0.39,0.25,0.5,0.44,0.33,0.33,0.5,0.33,0.78,0.44,0.5,0.25,0.28,0.5,0.25,0.44,0.25,0.5,0.28,0.28,0.5,0.5,0.44,0.5,0.25,0.33,0.44,0.39,0.5,0.28,0.5,0.5,0.25,0.5,0.39,0.28,0.5,0.5,0.25,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">anti-JCV antibodies was performed in a blinded fashion using the </text>
   <text y="671.069" x="49.596,53.097,57.093,61.089,65.589,70.089,74.589,76.11,80.61,84.606,89.106,93.102,96.099,100.095,102.597,105.099,109.599,114.099,115.62,118.122,124.62,129.12,132.117,135.618,138.12,142.116,146.616,148.137,153.636,159.135,162.132,167.136,173.139,174.66,177.657,182.661,188.16,194.163,199.662,205.161,208.158,213.162,219.327,220.848,224.349,230.352,236.688,238.209,244.707,249.207,254.211,258.207,260.709,264.705,268.701" svgx:width="0.39,0.44,0.44,0.5,0.5,0.5,0.25,0.5,0.44,0.5,0.44,0.33,0.44,0.28,0.28,0.5,0.5,0.25,0.28,0.72,0.5,0.33,0.39,0.28,0.44,0.5,0.25,0.61,0.61,0.33,0.56,0.72,0.25,0.33,0.56,0.61,0.67,0.72,0.61,0.33,0.56,0.72,0.25,0.39,0.67,0.72,0.25,0.72,0.5,0.56,0.44,0.28,0.44,0.44,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">second generation two-step ELISA (STRATIFY JCV DxSelect</text>
   <text y="668.583" x="271.238,274.812" svgx:width="0.61,0.89" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">TM</text>
   <text y="671.103" x="280.013,283.01" svgx:width="0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">).</text>
   <text y="682.101" x="49.604,56.102,60.098,63.599,68.603,71.105,74.102,77.603,80.6" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="682.101" x="84.974,91.472,93.974,96.476,98.726,100.85,105.35,107.6,109.724,114.224,117.221,121.217,124.214,129.218,137.219,142.385,144.635,146.759,150.26,154.256,161.258,165.758,168.26,172.256,175.757,178.007,180.131,186.629,190.625,193.622,197.618,199.868,201.992,205.493,209.489,212.486,216.986,221.486,225.986,229.487,231.989,234.491,236.993,241.493,245.489,247.739,249.989,252.113,257.117,260.114,264.11,267.107,272.111,280.112,285.278" svgx:width="0.72,0.28,0.28,0.25,0.55,0.5,0.25,0.55,0.5,0.33,0.44,0.33,0.56,0.89,0.61,0.25,0.55,0.39,0.44,0.78,0.5,0.28,0.44,0.39,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.39,0.44,0.33,0.5,0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.44,0.25,0.25,0.55,0.56,0.33,0.44,0.33,0.56,0.89,0.61,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">All 6 pre-PML samples were seropositive. Pre-PML </text>
   <text y="693.099" x="49.604,53.105,57.101,64.103,68.603,71.105,75.101,78.602,80.501,84.002,88.502,93.002,99.5,103.496,107.996,109.895,114.395,116.897,121.397,125.897,129.893,132.89,134.789,138.785,143.285,145.787,148.289,152.789,157.289,161.789,166.289,168.188,170.69,175.19,179.69,183.686,188.186,190.085,193.082,197.582,199.832,204.332,206.231,209.228,213.728,215.978,220.478,223.475,227.975,230.225,234.725,237.722,239.972,241.871,248.873,252.869,257.369,259.871,263.867,268.367,270.266,273.263,277.763,282.263" svgx:width="0.39,0.44,0.78,0.5,0.28,0.44,0.39,0.25,0.39,0.5,0.5,0.72,0.44,0.5,0.25,0.5,0.28,0.5,0.5,0.44,0.33,0.25,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.5,0.25,0.28,0.5,0.5,0.44,0.5,0.25,0.33,0.5,0.25,0.5,0.25,0.33,0.5,0.25,0.5,0.33,0.5,0.25,0.5,0.33,0.25,0.25,0.78,0.44,0.5,0.28,0.44,0.5,0.25,0.33,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">samples showed higher antibody index (3.6 (3.5-3.6), median (25-</text>
   <text y="704.097" x="49.604,54.104,58.604,60.854,62.501,67.001,70.997,73.994,77.99,81.986,86.486,88.988,91.49,93.992,97.988,100.985,103.982,106.232,107.879,110.381,114.881,118.877,123.377,125.627,127.274,130.775,134.771,137.768,142.268,146.768,151.268,154.769,157.271,159.773,162.275,166.775,170.771,173.021,174.668,179.168,183.164,185.666,188.168,192.164,196.664,199.166,202.667,204.917,206.564,213.062,217.562,222.062,224.312,225.959,230.459,232.961,237.461,239.711,241.358,245.858,250.358,252.86,255.11,256.757,261.257,265.253,269.753,273.749,276.251,280.751,285.251" svgx:width="0.5,0.5,0.25,0.55,0.5,0.44,0.33,0.44,0.44,0.5,0.28,0.28,0.28,0.44,0.33,0.33,0.25,0.55,0.28,0.5,0.44,0.5,0.25,0.55,0.39,0.44,0.33,0.5,0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.44,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.72,0.5,0.5,0.25,0.55,0.5,0.28,0.5,0.25,0.55,0.5,0.5,0.28,0.25,0.55,0.5,0.44,0.5,0.44,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">75 percentile)) than seropositive patients who did not develop </text>
   <text y="715.095" x="49.604,54.608,62.609,67.775,70.115,73.112,77.612,82.688,87.188,91.688,96.188,98.69,101.03,105.53,107.78,112.28,114.62,117.617,122.117,124.367,128.867,131.864,136.364,138.614,143.114,146.111,148.613,150.953,155.453,160.529,162.869,167.369,169.619,174.119,178.619,183.119,187.619,190.616,192.866,195.206,198.203,200.705,203.702,207.203,209.705,212.045,216.545,219.542,221.882,224.384,228.884,233.384,237.884,240.386,242.888,247.388,251.888,254.39,258.89,262.886,265.388,267.728,271.229,275.225,282.227" svgx:width="0.56,0.89,0.61,0.25,0.33,0.5,0.56,0.5,0.5,0.5,0.28,0.25,0.5,0.25,0.5,0.25,0.33,0.5,0.25,0.5,0.33,0.5,0.25,0.5,0.33,0.28,0.25,0.5,0.56,0.25,0.5,0.25,0.5,0.5,0.5,0.5,0.33,0.25,0.25,0.33,0.28,0.33,0.39,0.28,0.25,0.5,0.33,0.25,0.28,0.5,0.5,0.5,0.28,0.28,0.5,0.5,0.28,0.5,0.44,0.28,0.25,0.39,0.44,0.78,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">PML (n=269; 2.4 (1.0-3.1); p= 0.0492), first of longitudinal sam-</text>
   <text y="726.093" x="49.604,54.104,56.606,60.602,64.103,66.353,70.133,74.129,78.629,82.625,85.127,89.627,93.623,97.619,102.119,105.116,107.366,109.616,112.901,119.399,121.901,125.402,129.902,132.152,135.932,138.434,142.934,147.434,151.934,154.436,156.938,161.438,165.938,168.44,172.94,176.936,179.438,181.94,186.44,188.69,192.47,196.97,199.472,203.972,208.472,210.722,214.502,218.498,222.998,225.5,228.002,230.252,234.032,237.533,243.536,249.206,252.203,254.705,259.205,263.705,267.701,272.201,274.451,278.231,280.733,285.233" svgx:width="0.5,0.28,0.44,0.39,0.25,0.55,0.44,0.5,0.44,0.28,0.5,0.44,0.44,0.5,0.33,0.25,0.25,0.55,0.72,0.28,0.39,0.5,0.25,0.55,0.28,0.5,0.5,0.5,0.28,0.28,0.5,0.5,0.28,0.5,0.44,0.28,0.28,0.5,0.25,0.55,0.5,0.28,0.5,0.5,0.25,0.55,0.44,0.5,0.28,0.28,0.25,0.55,0.39,0.67,0.72,0.33,0.28,0.5,0.5,0.44,0.5,0.25,0.55,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ples analyzed). Also longitudinally high anti JCV-index in </text>
  </g>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.44;" d="M297.260 303.300 L360.490 303.300 "/>
  <g begin="text">
   <text y="77.103" x="297.26,301.76,304.757,308.753,311.75,316.754,324.755,329.921,332.171,334.034,337.535,341.531,348.533,353.033,355.535,359.531,363.032,365.282,367.145,370.142,374.138,381.14,385.136,387.638,392.138,396.134,400.634,402.884,404.747,408.248,410.75,414.746,419.246,421.748,425.744,427.994,429.857,432.854,437.354,439.604,444.104,446.354,448.217,451.214,455.714,457.964,462.464,465.461,469.961,472.211,476.711,479.708,481.958,484.208,486.071,490.571,492.821,497.321,499.571,501.434,504.431,508.931,511.181,515.681,518.678,523.178,525.428,529.928,532.925" svgx:width="0.5,0.33,0.44,0.33,0.56,0.89,0.61,0.25,0.55,0.39,0.44,0.78,0.5,0.28,0.44,0.39,0.25,0.55,0.33,0.44,0.78,0.44,0.28,0.5,0.44,0.5,0.25,0.55,0.39,0.28,0.44,0.5,0.28,0.44,0.25,0.55,0.33,0.5,0.25,0.5,0.25,0.55,0.33,0.5,0.25,0.5,0.33,0.5,0.25,0.5,0.33,0.25,0.25,0.55,0.5,0.25,0.5,0.25,0.55,0.33,0.5,0.25,0.5,0.33,0.5,0.25,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">pre-PML samples remained stable (3.6 (3.2-3.8), 3.7 (3.6-9.1) </text>
   <text y="88.101" x="297.26,304.262,308.762,313.262,315.764,320.264,323.765,326.015,328.517,333.017,335.519,339.515,342.512,347.012,351.008,353.51,356.507" svgx:width="0.78,0.5,0.5,0.28,0.5,0.39,0.25,0.28,0.5,0.28,0.44,0.33,0.5,0.44,0.28,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">months interval).</text>
   <text y="99.099" x="309.257,313.757,318.257,321.146,325.646,328.643,331.532,336.032,340.532,345.032,347.921,352.421,356.417,358.919,361.421,365.417,369.917,372.419,375.92,378.809,381.806,385.973,390.473,392.723,397.223,404.72,407.222,410.111,414.611,422.108,424.997,429.497,432.494,435.383,437.885,442.385,446.381,449.27,451.772,456.272,458.774,462.77,465.272,468.161,472.157,476.657,481.157,485.657,488.654,491.156,494.153,497.042,503.54,508.04,512.54,515.429,521.927,525.923,528.92,532.916" svgx:width="0.5,0.5,0.25,0.5,0.33,0.25,0.5,0.5,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.33,0.5,0.5,0.25,0.5,0.83,0.28,0.25,0.5,0.83,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.28,0.5,0.28,0.44,0.28,0.25,0.44,0.5,0.5,0.5,0.33,0.28,0.33,0.25,0.72,0.5,0.5,0.25,0.72,0.44,0.33,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">17 of 150 patients (11.3%; 4% of the total cohort) who were </text>
   <text y="110.097" x="297.26,299.762,304.262,306.764,309.266,311.768,315.764,318.266,320.768,325.268,327.941,331.442,335.438,338.435,342.935,347.435,351.431,355.931,359.927,362.429,364.931,369.431,373.427,376.1,380.096,384.596,389.096,393.596,397.592,400.589,403.091,407.087,411.587,414.251,416.753,421.253,423.917,427.418,431.414,434.411,438.911,443.411,447.911,451.412,453.914,456.416,458.918,463.418,465.92,468.422,472.922,475.595,480.095,484.595,488.591,491.588,494.252,498.248,502.748,505.421,507.923,512.423,514.925,518.921,521.918,526.418,530.414,532.916" svgx:width="0.28,0.5,0.28,0.28,0.28,0.44,0.28,0.28,0.5,0.25,0.39,0.44,0.33,0.5,0.5,0.44,0.5,0.44,0.28,0.28,0.5,0.44,0.25,0.44,0.5,0.5,0.5,0.44,0.33,0.28,0.44,0.5,0.25,0.28,0.5,0.25,0.39,0.44,0.33,0.5,0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.5,0.5,0.44,0.33,0.25,0.44,0.5,0.25,0.28,0.5,0.28,0.44,0.33,0.5,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">initially seronegative converted to seropositivity over an interval </text>
   <text y="121.095" x="297.26,301.76,304.757,306.53,311.03,313.28,317.78,319.553,322.55,327.05,329.3,333.8,336.797,340.964,345.464,347.714,352.214,355.211,356.984,363.986,368.486,372.986,375.488,379.988,383.489,385.739,387.512,392.012,396.512,398.285,402.785,405.782,407.555,410.057,414.557,418.553,422.054,426.05,427.823,432.323,436.823,438.596,443.096,447.092,449.594,452.096,456.092,460.592,463.094,466.595,468.368,471.365,475.865,480.365,482.615,487.115,494.612,497.609,499.382,502.379,506.375,513.377,517.373,519.875,524.375,528.371,532.871" svgx:width="0.5,0.33,0.25,0.5,0.25,0.5,0.25,0.33,0.5,0.25,0.5,0.33,0.5,0.5,0.25,0.5,0.33,0.25,0.78,0.5,0.5,0.28,0.5,0.39,0.25,0.25,0.5,0.5,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.39,0.44,0.25,0.5,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.33,0.5,0.5,0.25,0.5,0.83,0.33,0.25,0.33,0.44,0.78,0.44,0.28,0.5,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">of 7.4 (4.3-11.9) months. 10 of these 17 patients (58.8%) remained </text>
   <text y="132.093" x="297.26,301.76,305.756,308.258,312.758,319.256,321.74,324.242,328.742,332.738,335.222,339.218,343.718,346.22,348.722,351.719,355.22,361.223,367.559,370.043,372.545,377.045,381.545,385.541,390.041,392.525,395.027,399.527,402.524,406.52,410.021,414.521,419.021,421.523,426.023,428.507,433.007,436.004,438.488,442.988,445.238,449.738,452.222,456.722,461.222,465.218,468.215,470.699,474.695,479.195,481.679,484.181,488.681,491.183,495.179,498.176,502.676,506.672,509.174,511.658,516.158,519.155,521.639,526.139,528.389,532.889" svgx:width="0.5,0.44,0.28,0.5,0.72,0.25,0.28,0.5,0.44,0.25,0.44,0.5,0.28,0.28,0.33,0.39,0.67,0.72,0.25,0.28,0.5,0.5,0.44,0.5,0.25,0.28,0.5,0.33,0.44,0.39,0.5,0.5,0.28,0.5,0.25,0.5,0.33,0.25,0.5,0.25,0.5,0.25,0.5,0.5,0.44,0.33,0.25,0.44,0.5,0.25,0.28,0.5,0.28,0.44,0.33,0.5,0.44,0.28,0.25,0.5,0.33,0.25,0.5,0.25,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">below the anti-JCV index threshold of 0.9 over an interval of 6.9 </text>
   <text y="143.091" x="297.26,300.257,304.757,307.007,311.507,314.504,319.004,323.504,325.754,330.254,333.251,335.501,336.797,343.799,348.299,352.799,355.301,359.801,363.302,365.552,367.802,369.098,373.598,378.098,380.348,381.635,386.135,389.132,391.382,392.678,397.178,401.678,406.178,408.428,409.724,414.224,418.22,420.722,423.224,427.22,431.72,434.222,437.723,439.973,441.269,444.266,448.766,451.016,455.516,463.013,465.515,467.765,469.052,473.552,475.802,480.302,487.799,490.049,491.345,495.845,498.842,501.092,502.388,504.89,509.39,513.386,515.636,516.932,519.434,523.934,526.436,530.432,532.934" svgx:width="0.33,0.5,0.25,0.5,0.33,0.5,0.5,0.25,0.5,0.33,0.25,0.55,0.78,0.5,0.5,0.28,0.5,0.39,0.25,0.25,0.55,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.5,0.5,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.33,0.5,0.25,0.5,0.83,0.28,0.25,0.55,0.5,0.25,0.5,0.83,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.28,0.5,0.28,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(4.5-10.8) months. 10 of 272 patients (3.6%; 2.4% of the total </text>
   <text y="154.089" x="297.26,301.256,305.756,310.256,314.756,317.753,320.255,323.252,325.502,326.42,329.921,333.917,336.914,341.414,345.914,350.414,353.915,356.417,358.919,361.421,365.921,369.917,372.167,373.085,377.081,379.583,381.833,382.751,385.748,388.25,391.247,394.748,397.25,399.5,400.418,402.92,406.916,410.417,412.919,415.421,419.921,424.421,426.671,427.589,430.586,434.582,439.082,443.078,446.075,448.577,452.573,457.073,459.323,460.241,463.238,466.235,470.735,477.737,479.987,480.905,484.901,489.401,491.903,494.405,497.402,500.903,506.906,513.242,515.492,516.41,520.406,524.906,527.408,529.91" svgx:width="0.44,0.5,0.5,0.5,0.33,0.28,0.33,0.25,0.55,0.39,0.44,0.33,0.5,0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.44,0.25,0.55,0.44,0.28,0.25,0.55,0.33,0.28,0.33,0.39,0.28,0.25,0.55,0.28,0.44,0.39,0.28,0.28,0.5,0.5,0.25,0.55,0.33,0.44,0.5,0.44,0.33,0.28,0.44,0.5,0.25,0.55,0.33,0.33,0.5,0.78,0.25,0.55,0.44,0.5,0.28,0.28,0.33,0.39,0.67,0.72,0.25,0.55,0.44,0.5,0.28,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">cohort) seropositive at first testing reverted from anti-JCV anti-</text>
   <text y="165.087" x="297.26,301.76,306.26,310.76,315.26,318.257,322.757,327.257,330.758,333.26,335.762,338.264,342.764,346.76,349.01,349.748,352.25,356.75,359.0,359.738,362.735,367.235,371.231,375.731,379.727,382.229,384.731,389.231,393.227,395.477,397.97,404.468,408.968,411.47,413.972,418.472,422.972,427.472,431.972,434.222,434.96,437.462,441.458,445.958,449.954,452.456,455.957,458.207,458.945,461.447,465.947,470.447,472.949,476.945,480.941,483.443,487.439,489.689,490.427,493.424,495.926,500.426,504.422,506.924,511.424,515.42,517.922,520.424,524.924,529.424,532.925" svgx:width="0.5,0.5,0.5,0.5,0.33,0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.44,0.25,0.55,0.28,0.5,0.25,0.55,0.33,0.5,0.44,0.5,0.44,0.28,0.28,0.5,0.44,0.25,0.25,0.72,0.5,0.28,0.28,0.5,0.5,0.5,0.5,0.25,0.55,0.28,0.44,0.5,0.44,0.28,0.39,0.25,0.55,0.28,0.5,0.5,0.28,0.44,0.44,0.28,0.44,0.25,0.55,0.33,0.28,0.5,0.44,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">body-positive to -negative. Antibody levels indicate fluctuations </text>
   <text y="176.085" x="297.26,301.256,304.253,308.753,313.253,317.753,322.253,324.503,326.366,328.868,333.368,337.364,339.614,341.477,343.979,348.479,354.977,358.973,361.97,364.22,366.083,370.079,374.579,377.081,379.331,381.194,385.694,390.194,392.696,397.196,399.698,401.948,403.811,408.311,411.308,413.558,415.421,417.923,422.423,426.419,428.669,430.532,434.528,438.029,441.53,445.526,449.441,451.691,453.941,455.804,460.808,464.804,467.801,472.301,476.801,481.301,484.802,487.304,489.806,492.308,496.808,500.804,503.054,504.917,509.417,513.413,515.915,518.417,522.413,526.913,529.415,532.916" svgx:width="0.44,0.33,0.5,0.5,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.28,0.5,0.72,0.44,0.33,0.25,0.55,0.44,0.5,0.28,0.25,0.55,0.5,0.5,0.28,0.5,0.28,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.44,0.39,0.39,0.44,0.5,0.25,0.25,0.55,0.56,0.44,0.33,0.5,0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.44,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">around the lower cut point of the assay. Seropositive patients </text>
   <text y="187.083" x="297.26,300.761,305.261,309.761,316.259,320.255,324.755,327.122,331.118,333.494,336.995,339.497,341.999,346.499,350.999,353.501,355.877,360.377,364.373,368.369,371.366,375.362,379.358,382.859,386.855,389.222,391.724,396.224,398.6,401.102,405.602,410.102,414.098,418.598,420.974,423.971,426.968,431.468,433.718,438.218,440.594,443.591,446.588,451.088,453.338,457.838,460.205,462.707,467.207,469.583,472.58,477.08,479.33,483.83,486.827,489.194,493.694,498.194,502.19,505.187,507.563,511.559,513.935,518.435,522.935,525.932,529.928" svgx:width="0.39,0.5,0.5,0.72,0.44,0.5,0.25,0.44,0.25,0.39,0.28,0.28,0.5,0.5,0.28,0.25,0.5,0.44,0.44,0.33,0.44,0.44,0.39,0.44,0.25,0.28,0.5,0.25,0.28,0.5,0.5,0.44,0.5,0.25,0.33,0.33,0.5,0.25,0.5,0.25,0.33,0.33,0.5,0.25,0.5,0.25,0.28,0.5,0.25,0.33,0.5,0.25,0.5,0.33,0.25,0.5,0.5,0.44,0.33,0.25,0.44,0.25,0.5,0.5,0.33,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">showed a slight decrease in index (-0.1 (-0.3 to -0.1) over a dura-</text>
   <text y="198.081" x="297.26,299.762,302.264,306.764,311.264,313.514,318.014,321.011,323.261,327.761,330.011,334.511,336.761,339.758,344.258,346.508,351.008,354.005,358.505,360.755,365.255,368.252,370.502,377.504,382.004,386.504,389.006,393.506,397.007,399.257,402.254,406.754,411.83,416.33,418.58,423.08,427.58,432.08,436.58,439.577" svgx:width="0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.5,0.25,0.5,0.25,0.33,0.5,0.25,0.5,0.33,0.5,0.25,0.5,0.33,0.25,0.78,0.5,0.5,0.28,0.5,0.39,0.25,0.33,0.5,0.56,0.5,0.25,0.5,0.5,0.5,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tion of 5.5 (3.3-8.7) months (p=0.0007).</text>
   <text y="209.079" x="297.26,303.758,308.258,313.262,317.258,319.76,324.764,328.265,330.767,335.267,340.271,343.772,346.769" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="209.079" x="349.541,356.039,360.539,363.536,366.308,370.808,374.804,377.306,381.302,384.074,387.071,390.068,394.568,401.57,404.342,408.338,412.838,415.61,418.112,422.612,427.112,431.108,435.608,439.604,444.104,448.604,452.6,457.1,459.602,462.374,468.872,472.868,475.865,482.867,486.863,491.363,494.135,498.131,502.631,507.131,511.631,514.628,517.13,519.902,522.899,527.399,529.901" svgx:width="0.72,0.5,0.33,0.25,0.5,0.44,0.28,0.44,0.25,0.33,0.33,0.5,0.78,0.25,0.44,0.5,0.25,0.28,0.5,0.5,0.44,0.5,0.44,0.5,0.5,0.44,0.5,0.28,0.25,0.72,0.44,0.33,0.78,0.44,0.5,0.25,0.44,0.5,0.5,0.5,0.33,0.28,0.25,0.33,0.5,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Our data from an independent German cohort fol-</text>
   <text y="220.077" x="297.26,299.762,304.262,310.76,314.756,319.256,321.506,322.325,326.825,331.325,333.575,334.394,336.896,341.396,343.646,344.465,346.967,351.467,355.463,357.713,358.532,363.032,367.532,371.033,373.535,375.785,376.604,383.606,387.602,390.599,395.099,399.095,401.597,404.099,408.599,413.099,415.349,416.168,419.669,423.665,426.167,428.669,431.171,435.671,440.171,442.421,443.24,446.741,451.241,455.741,460.241,464.741,467.738,470.24,473.741,475.991,476.81,479.312,483.812,487.808,490.058,490.877,495.377,499.877,502.379,506.375,510.875,513.377,515.879,519.875,522.377,524.627,525.446,529.946,532.943" svgx:width="0.28,0.5,0.72,0.44,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.5,0.39,0.28,0.25,0.55,0.78,0.44,0.33,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.39,0.44,0.28,0.28,0.28,0.5,0.5,0.25,0.55,0.39,0.5,0.5,0.5,0.5,0.33,0.28,0.39,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.5,0.28,0.44,0.5,0.28,0.28,0.44,0.28,0.25,0.55,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">lowed up in the post marketing setting supports the potential of </text>
   <text y="231.075" x="297.26,301.256,305.756,308.258,310.76,313.424,316.925,322.928,328.598,331.595,334.097,338.597,343.097,347.093,351.593,354.257,356.759,361.259,363.923,366.92,371.42,374.417,376.919,381.419,385.415,388.412,391.076,394.073,398.069,401.066,403.568,408.068,412.064,414.728,417.23,421.73,425.726,428.39,431.387,433.889,437.39,441.89,444.554,447.056,451.556,454.22,458.72,462.716,467.216,471.212,473.714,478.214,482.714,485.378,490.382,498.383,503.882,506.132,508.796,515.294,518.795,522.791,525.455,529.955,532.952" svgx:width="0.44,0.5,0.28,0.28,0.25,0.39,0.67,0.72,0.33,0.28,0.5,0.5,0.44,0.5,0.25,0.28,0.5,0.25,0.33,0.5,0.33,0.28,0.5,0.44,0.33,0.25,0.33,0.44,0.33,0.28,0.5,0.44,0.25,0.28,0.5,0.44,0.25,0.33,0.28,0.39,0.5,0.25,0.28,0.5,0.25,0.5,0.44,0.5,0.44,0.28,0.5,0.5,0.25,0.56,0.89,0.61,0.25,0.25,0.72,0.39,0.44,0.25,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">anti JCV-index to further refine the risk to develop PML. Use of </text>
   <text y="242.073" x="297.26,301.256,305.756,308.258,310.76,313.01,314.09,317.591,323.594,329.264,332.261,334.763,339.263,343.763,347.759,352.259,354.509,355.589,362.591,366.587,371.087,373.337,374.417,378.413,380.915,384.416,388.916,391.166,392.246,396.242,399.743,403.244,405.746,409.247,411.749,413.999,415.079,417.581,422.081,424.331,425.411,428.408,430.91,434.411,438.911,441.161,442.241,445.742,448.244,451.241,455.237,457.739,460.241,463.238,465.74,469.736,473.732,476.234,478.736,483.236,487.736,489.986,491.066,494.063,498.563,501.56,503.81,504.89,509.39,513.386,515.888,518.39,522.386,526.886,529.388,532.889" svgx:width="0.44,0.5,0.28,0.28,0.25,0.55,0.39,0.67,0.72,0.33,0.28,0.5,0.5,0.44,0.5,0.25,0.55,0.78,0.44,0.5,0.25,0.55,0.44,0.28,0.39,0.5,0.25,0.55,0.44,0.39,0.39,0.28,0.39,0.28,0.25,0.55,0.28,0.5,0.25,0.55,0.33,0.28,0.39,0.5,0.25,0.55,0.39,0.28,0.33,0.44,0.28,0.28,0.33,0.28,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.33,0.5,0.33,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">anti JCV-index may also assist in risk stratification for patients </text>
   <text y="253.071" x="297.26,303.758,306.26,308.762,313.262,315.512,319.508,324.008,328.004,332.504,337.004,339.506,344.006,348.506,350.756,354.257,358.253,361.25,365.75,369.251,371.753,375.749,378.251,382.751,386.252" svgx:width="0.72,0.28,0.28,0.5,0.25,0.44,0.5,0.44,0.5,0.5,0.28,0.5,0.5,0.25,0.39,0.44,0.33,0.5,0.39,0.28,0.44,0.28,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">with changing serostatus.</text>
   <text y="280.071" x="297.26,302.759,307.259,311.759" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P870</text>
   <text y="291.069" x="297.26,303.263,307.763,310.76,314.756,317.006,321.506,326.51,330.011,334.007,337.004,339.254,344.753,353.249,359.252,361.502,364.004,369.008,371.258,375.758,378.008,383.012,387.512,390.509,395.009,397.511,400.013,404.009,409.013,416.51,421.01,426.014,429.011,432.008,436.004,440.0,444.5,447.497,451.493,456.497,458.747,467.243,472.247,474.497,479.501,484.001,486.998,489.5,493.496,498.5" svgx:width="0.67,0.5,0.33,0.44,0.25,0.5,0.56,0.39,0.44,0.33,0.25,0.61,0.94,0.67,0.25,0.28,0.56,0.25,0.5,0.25,0.56,0.5,0.33,0.5,0.28,0.28,0.44,0.56,0.83,0.5,0.56,0.33,0.33,0.44,0.44,0.5,0.33,0.44,0.56,0.25,0.94,0.56,0.25,0.56,0.5,0.33,0.28,0.44,0.56,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Late onset PML in a natalizumab-treated MS patient</text>
   <text y="302.067" x="297.26,303.263,308.762,311.012,317.51,321.506,324.503,328.499,332.999,336.995,341.495,344.492,348.992,351.494,355.994" svgx:width="0.67,0.61,0.25,0.72,0.44,0.33,0.44,0.5,0.44,0.5,0.33,0.5,0.28,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">CE Karageorgiou</text>
   <text y="299.583" x="360.493,363.418,364.88" svgx:width="0.5,0.25,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1,2</text>
   <text y="302.103" x="367.806,370.056,372.306,377.805,380.055,386.552,389.055,393.051,397.551,402.051,406.551,411.051,413.553" svgx:width="0.25,0.25,0.61,0.25,0.72,0.28,0.44,0.5,0.5,0.5,0.5,0.28,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, E Giannouli</text>
   <text y="299.583" x="416.054,418.979,420.442" svgx:width="0.5,0.25,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1,2</text>
   <text y="302.103" x="423.367,425.617,427.867,434.365,436.615,443.113,447.109,450.106,454.606,458.602,463.102,467.602" svgx:width="0.25,0.25,0.72,0.25,0.72,0.44,0.33,0.5,0.44,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, A Kargadou</text>
   <text y="299.583" x="472.101" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="302.103" x="475.026,477.276,479.526,486.024" svgx:width="0.25,0.25,0.72,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, A </text>
   <text y="313.101" x="297.258,303.756,306.258,310.758,314.754,319.254,323.25,326.751,331.251,335.751,338.253" svgx:width="0.72,0.28,0.5,0.44,0.5,0.44,0.39,0.5,0.5,0.28,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Athanasouli</text>
   <text y="310.583" x="340.756" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="313.103" x="343.681,345.931,348.181,354.679,356.929,362.428,369.43,373.426,377.926,382.426,386.926,389.428" svgx:width="0.25,0.25,0.72,0.25,0.61,0.78,0.44,0.5,0.5,0.5,0.28,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, G Emanouil</text>
   <text y="310.583" x="391.93" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="321.581" x="297.259" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="324.103" x="300.185,305.684,308.186,312.686,316.682,321.182,324.683,326.933,334.43,338.426,342.926,345.428,349.424,353.924,356.426,358.676,364.679,368.675,373.175,375.677,379.673,383.174,385.424,387.674,393.173,395.675,400.175,404.171,408.671,412.172,414.422,416.672,423.17,426.671,430.667,434.663,438.659,442.655,444.905" svgx:width="0.61,0.28,0.5,0.44,0.5,0.39,0.25,0.83,0.44,0.5,0.28,0.44,0.5,0.28,0.25,0.67,0.44,0.5,0.28,0.44,0.39,0.25,0.25,0.61,0.28,0.5,0.44,0.5,0.39,0.25,0.25,0.72,0.39,0.44,0.44,0.44,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Athens Medical Center, Athens, Greece, </text>
   <text y="321.583" x="447.153" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">2</text>
   <text y="324.103" x="450.078,456.081,460.077,464.577,468.078,472.578,475.08,479.58,484.08,486.582,490.578,495.078,497.58,499.83,502.827,507.327,510.828,513.33,515.832,518.334,522.834,525.336,529.332" svgx:width="0.67,0.44,0.5,0.39,0.5,0.28,0.5,0.5,0.28,0.44,0.5,0.28,0.25,0.33,0.5,0.39,0.28,0.28,0.28,0.5,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Neurological Institute </text>
   <text y="335.101" x="297.258,301.758,304.26,306.51,312.009,314.511,319.011,323.007,327.507,331.008,333.258,335.508,341.007,343.509,348.009,352.005,356.505,360.006,362.256,364.506,371.004,374.505,378.501,382.497,386.493" svgx:width="0.5,0.28,0.25,0.61,0.28,0.5,0.44,0.5,0.39,0.25,0.25,0.61,0.28,0.5,0.44,0.5,0.39,0.25,0.25,0.72,0.39,0.44,0.44,0.44,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">of Athens, Athens, Greece</text>
   <text y="362.101" x="297.258,303.261,307.761,311.757,316.761,321.261,325.095,329.595,334.599,339.603,344.607,347.604" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="362.101" x="357.72,362.724,365.721,370.221,374.721,377.718,381.714,385.215,388.716,391.218,395.718,399.714,401.964,409.83,416.832,421.332,423.834,426.336,428.838,431.835,436.335,440.331,444.327,446.829,449.079,456.945,459.447,463.443,467.943,471.939,476.439,480.435,484.935,488.931,492.927,497.427,501.927,505.923,508.425,512.925,517.425,521.421,523.923,528.423,532.923" svgx:width="0.56,0.33,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.44,0.25,0.55,0.78,0.5,0.28,0.28,0.28,0.33,0.5,0.44,0.44,0.28,0.25,0.55,0.28,0.44,0.5,0.44,0.5,0.44,0.5,0.44,0.44,0.5,0.5,0.44,0.28,0.5,0.5,0.44,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Progressive multifocal leucoencephalopathy </text>
   <text y="373.099" x="297.258,300.255,305.259,313.26,318.759,321.756,324.006,324.771,327.273,330.774,333.024,333.789,337.785,340.035,340.8,347.298,351.294,353.796,356.298,359.295,363.795,368.295,372.291,376.791,383.793,387.789,392.289,394.791,398.787,403.287,405.537,406.302,409.803,412.305,416.805,420.801,423.051,423.816,427.812,430.647,433.644,437.64,441.636,444.138,446.388,447.153,451.653,454.65,456.9,457.665,462.165,466.161,468.663,472.659,475.161,477.663,481.659,486.159,493.161,497.157,501.657,503.907,506.157,506.922,510.918,513.168,513.933,516.435,519.432,523.428,527.424,529.926" svgx:width="0.33,0.56,0.89,0.61,0.33,0.25,0.55,0.28,0.39,0.25,0.55,0.44,0.25,0.55,0.72,0.44,0.28,0.28,0.33,0.5,0.5,0.44,0.5,0.78,0.44,0.5,0.28,0.44,0.5,0.25,0.55,0.39,0.28,0.5,0.44,0.25,0.55,0.44,0.33,0.33,0.44,0.44,0.28,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.25,0.25,0.55,0.44,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(PML) is a well-documented side effect of natalizumab, a treat-</text>
   <text y="384.097" x="297.258,304.26,308.256,312.756,315.258,317.418,320.415,324.915,327.912,330.072,338.073,342.573,345.075,347.577,350.079,354.579,357.081,361.077,363.237,368.241,372.237,374.739,378.735,381.732,386.232,389.733,392.235,395.736,397.896,400.893,408.894,413.898,416.895,419.145,421.305,426.309,434.31,439.476,441.636,444.633,447.135,450.636,455.136,457.296,459.798,463.299,465.459,469.455,473.955,478.455,482.451,486.447,488.949,492.945,497.445,499.605,502.107,506.607,508.767,513.267,517.263,519.423,521.925,526.425,532.923" svgx:width="0.78,0.44,0.5,0.28,0.25,0.33,0.5,0.33,0.25,0.89,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.56,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25,0.33,0.89,0.56,0.33,0.25,0.25,0.56,0.89,0.61,0.25,0.33,0.28,0.39,0.5,0.25,0.28,0.39,0.25,0.44,0.5,0.5,0.44,0.44,0.28,0.44,0.5,0.25,0.28,0.5,0.25,0.5,0.44,0.25,0.28,0.5,0.72,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ment for Multiple Sclerosis (MS). PML risk is expected to be low </text>
   <text y="395.095" x="297.258,303.756,308.256,312.252,316.752,319.002,321.441,323.943,328.443,332.439,334.689,337.128,341.628,344.625,349.125,353.625,355.875,358.314,360.816,364.317,366.567,369.006,373.002,375.504,378.006,385.008,387.51,392.01,396.006,398.508,402.504,407.004,409.254,411.693,414.69,417.687,422.187,429.189,431.439,433.878,436.38,440.88,444.876,447.126,449.565,454.065,458.565,463.065,467.565,469.815,472.254,475.251,481.749,485.745,489.246,493.746,498.246,502.746,505.248,507.498,509.937,514.437,518.433,521.43,523.932,528.432,532.932" svgx:width="0.72,0.5,0.44,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.33,0.5,0.5,0.25,0.55,0.28,0.39,0.25,0.55,0.44,0.28,0.28,0.78,0.28,0.5,0.44,0.28,0.44,0.5,0.25,0.55,0.33,0.33,0.5,0.78,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.5,0.5,0.5,0.25,0.55,0.33,0.72,0.44,0.39,0.5,0.5,0.5,0.28,0.25,0.55,0.5,0.44,0.33,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">when the drug is eliminated from the body (washout period </text>
   <text y="406.093" x="297.258,301.254,305.754,310.254,313.251,317.751,322.251,324.753,331.755,335.751,338.253,342.249,344.751,349.251,351.501,356.001,358.251,365.253,369.753,374.253,376.755,381.255,384.756,387.753" svgx:width="0.44,0.5,0.5,0.33,0.5,0.5,0.28,0.78,0.44,0.28,0.44,0.28,0.5,0.25,0.5,0.25,0.78,0.5,0.5,0.28,0.5,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">approximately 3 months).</text>
   <text y="417.091" x="297.258,304.26,309.264,312.261,316.257,320.253,323.25,325.752,330.252,334.248,337.749,340.746" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="417.091" x="343.716,351.492,355.488,357.738,358.467,362.967,365.964,369.96,373.461,377.457,381.957,384.459,386.709,387.429,391.425,393.675,394.395,398.391,402.387,405.888,409.884,412.134,412.863,417.363,420.36,422.61,423.33,428.334,436.335,441.501,443.751,444.48,446.982,451.482,453.732,454.452,458.448,460.698,461.427,465.927,469.923,472.425,476.421,478.923,481.425,485.421,489.921,496.923,500.919,505.419,508.416,510.918,513.915,517.911,521.907,524.409,528.405,532.905" svgx:width="0.94,0.44,0.25,0.55,0.5,0.33,0.44,0.39,0.44,0.5,0.28,0.25,0.55,0.44,0.25,0.55,0.44,0.44,0.39,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.56,0.89,0.61,0.25,0.55,0.28,0.5,0.25,0.55,0.44,0.25,0.55,0.5,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.33,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">We present a case of PML in a natalizumab-treated </text>
   <text y="428.089" x="297.258,305.259,310.263,312.513,315.258,319.758,323.754,326.256,328.758,332.754,337.254,339.756,342.006,344.751,347.253,351.753,354.75,358.746,362.742,364.992,367.737,371.733,376.233,380.733,382.983,385.728,389.724,391.974,394.719,399.219,403.215,405.717,408.714,410.964,413.709,416.706,421.206,423.456,427.956,430.953,433.203,435.948,442.95,447.45,451.95,454.452,458.952,462.453,464.703,467.448,471.444,474.441,476.943,480.939,483.936,486.186,488.931,493.431,497.427,499.929,503.925,506.427,508.929,512.925,517.425,524.427,528.423,532.923" svgx:width="0.89,0.56,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.25,0.55,0.28,0.5,0.33,0.44,0.44,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.44,0.25,0.55,0.5,0.44,0.28,0.33,0.25,0.55,0.33,0.5,0.25,0.5,0.33,0.25,0.55,0.78,0.5,0.5,0.28,0.5,0.39,0.25,0.55,0.44,0.33,0.28,0.44,0.33,0.25,0.55,0.5,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">MS patient three and a half (3,5) months after natalizumab </text>
   <text y="439.087" x="297.258,301.758,304.26,307.761,311.757,316.257,320.757,323.259,325.761,330.261,334.761,338.757,341.259,343.761,348.261,352.761" svgx:width="0.5,0.28,0.39,0.44,0.5,0.5,0.28,0.28,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">discontinuation.</text>
   <text y="450.085" x="297.258,305.844,309.93,313.017,318.111,322.701,327.795,331.386,334.473" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="450.085" x="338.208,344.301,346.551,348.036,352.626,357.216,360.303,364.893,368.979,373.065,375.972,379.059,383.649,386.241,390.831,393.081,394.566,397.653,401.739,408.831,412.917,415.509,419.595,421.935,424.185,425.67,430.26,432.852,436.938,441.528,446.118,450.708,454.299,458.385,462.975,465.225,466.71,473.298,475.89,478.482,483.072,485.322,486.807,494.898,499.992,502.242,503.727,506.319,510.909,513.159,514.644,519.234,523.824,528.414,532.914" svgx:width="0.72,0.25,0.55,0.5,0.5,0.33,0.5,0.44,0.44,0.33,0.33,0.5,0.28,0.5,0.25,0.55,0.33,0.44,0.78,0.44,0.28,0.44,0.25,0.25,0.55,0.5,0.28,0.44,0.5,0.5,0.5,0.39,0.44,0.5,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.89,0.56,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">A 37-year-old female, diagnosed with MS in 2002 </text>
   <text y="461.083" x="297.258,300.345,304.431,308.517,312.603,315.195,319.785,323.871,328.461,330.684,333.276,337.866,340.458,344.544,347.631,350.718,354.804,357.891,362.481,367.071,370.158,374.748,379.338,383.424,385.647,388.734,393.324,396.411,398.634,402.72,405.312,409.902,414.492,417.084,419.307,423.897,427.983,432.069,435.156,438.747,441.087,443.31,449.898,454.488,458.574,460.797,463.389,467.979,470.202,474.288,476.511,481.101,483.693,488.283,492.873,495.096,499.686,504.276,511.368,515.958,520.044,523.131,525.354,529.944,532.941" svgx:width="0.33,0.44,0.44,0.44,0.28,0.5,0.44,0.5,0.25,0.28,0.5,0.28,0.44,0.33,0.33,0.44,0.33,0.5,0.5,0.33,0.5,0.5,0.44,0.25,0.33,0.5,0.33,0.25,0.44,0.28,0.5,0.5,0.28,0.25,0.5,0.44,0.44,0.33,0.39,0.25,0.25,0.72,0.5,0.44,0.25,0.28,0.5,0.25,0.44,0.25,0.5,0.28,0.5,0.5,0.25,0.5,0.5,0.78,0.5,0.44,0.33,0.25,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">received interferon-b1a for eight years. Due to a high number of </text>
   <text y="472.081" x="297.258,300.345,304.431,307.023,311.109,315.699,319.29,323.376,326.967,329.217,330.657,335.247,339.333,341.925,346.011,348.603,351.195,355.281,359.871,366.963,371.049,375.639,377.889,379.329,385.917,390.003,393.594,395.844,397.284,399.876,404.466,407.058,409.65,412.242,416.328,418.92,423.006,427.596,429.846,431.286,435.372,439.962,444.552,446.802,448.242,450.834,455.424,459.51,461.76,463.2,467.79,471.876,474.468,477.06,481.146,485.736,488.328,490.92,494.511,496.761,498.201,502.287,506.877,511.467,516.057,518.649,521.241,523.833,528.423,532.923" svgx:width="0.33,0.44,0.28,0.44,0.5,0.39,0.44,0.39,0.25,0.55,0.5,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.28,0.5,0.28,0.28,0.28,0.44,0.28,0.44,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.33,0.39,0.25,0.55,0.44,0.5,0.5,0.5,0.28,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">relapses natalizumab was initiated and the patientâ€™s condition </text>
   <text y="483.079" x="297.258,300.849,303.441,307.527,312.117,314.709,317.301,319.893,323.979,328.065,332.655,334.905,335.823,338.91,343.5,346.587,348.837,349.755,354.345,356.685,361.275,363.525,364.443,369.033,373.119,377.205,380.292,383.883,386.133,387.051,390.138,395.727,402.315,407.409,412.503,415.095,417.345,418.263,422.853,425.94,428.19,429.108,433.698,438.288,440.88,443.13,444.048,446.64,451.23,455.316,459.906,462.156,463.074,465.666,470.256,474.342,476.592,477.51,482.1,485.187,489.777,494.367,496.617,497.535,502.125,506.211,510.801,513.0509999999999,513.969,516.561,521.151,523.401,524.319,528.909,532.905" svgx:width="0.39,0.28,0.44,0.5,0.28,0.28,0.28,0.44,0.44,0.5,0.25,0.55,0.33,0.5,0.33,0.25,0.55,0.5,0.25,0.5,0.25,0.55,0.5,0.44,0.44,0.33,0.39,0.25,0.55,0.33,0.61,0.72,0.56,0.56,0.28,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.5,0.28,0.25,0.55,0.28,0.5,0.44,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.33,0.5,0.5,0.25,0.55,0.5,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">stabilized for 2,5 years (EDSS: 5) but then the drug had to be </text>
   <text y="494.077" x="297.258,301.848,304.44,308.031,312.117,316.707,321.297,323.889,326.481,331.071,335.661,339.747,344.337,346.587,348.909,351.501,355.587,362.679,367.269,371.859,374.946,379.032,382.119,384.711,387.303,391.893,394.143,396.465,401.055,405.141,409.227,413.313,417.903,421.494,425.58,427.83,430.152,434.742,437.829,440.079,442.401,445.488,449.574,453.66,458.25,461.337,464.424,468.51,473.1,475.692,477.942,480.264,484.854,487.941,490.533,495.123,499.209,502.296,506.886,509.136,511.458,514.05,518.64,521.727,525.813,529.899" svgx:width="0.5,0.28,0.39,0.44,0.5,0.5,0.28,0.28,0.5,0.5,0.44,0.5,0.25,0.55,0.28,0.44,0.78,0.5,0.5,0.33,0.44,0.33,0.28,0.28,0.5,0.25,0.55,0.5,0.44,0.44,0.44,0.5,0.39,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.33,0.44,0.44,0.5,0.33,0.33,0.44,0.5,0.28,0.25,0.55,0.5,0.33,0.28,0.5,0.44,0.33,0.5,0.25,0.55,0.28,0.5,0.33,0.44,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">discontinued temporarily because of recurrent urinary infec-</text>
   <text y="505.075" x="297.258,299.85,302.442,307.032,311.622,315.213,317.553,320.307,325.896,330.486,334.572,337.488,342.078,346.164,348.756,351.348,355.434,360.024,362.616,365.208,368.799,371.715,375.801,380.391,384.981,389.571,392.163,394.755,397.347,401.937,406.527,409.443,416.031,420.117,423.708,426.624,430.215,432.807,436.893,441.483,444.075,448.161,451.077,454.164,458.754,461.841,464.757,467.349,471.939,475.026,479.112,483.198,486.114,493.206,497.796,502.386,504.978,509.568,513.159,516.075,520.161,523.248,525.84,529.926,532.923" svgx:width="0.28,0.28,0.5,0.5,0.39,0.25,0.25,0.61,0.5,0.44,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.33,0.39,0.25,0.44,0.5,0.5,0.5,0.28,0.28,0.28,0.5,0.5,0.25,0.72,0.44,0.39,0.25,0.39,0.28,0.44,0.5,0.28,0.44,0.25,0.33,0.5,0.33,0.25,0.28,0.5,0.33,0.44,0.44,0.25,0.78,0.5,0.5,0.28,0.5,0.39,0.25,0.44,0.33,0.28,0.44,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tions. The patientâ€™s condition was stable for three months after </text>
   <text y="516.073" x="297.258,301.848,305.934,308.526,312.612,315.204,317.796,321.882,326.472,333.564,337.65,342.24,344.49,346.254,350.844,353.436,357.027,361.113,365.703,370.293,372.885,375.477,380.067,384.657,388.743,391.335,393.927,398.517,403.107,405.357,407.121,411.207,415.797,420.387,422.637,424.401,428.991,433.581,436.173,440.763,443.013,444.777,448.863,453.453,460.545,465.135,467.727,471.813,474.405,478.995,483.081,487.671,489.921,491.685,496.275,499.362,501.612,503.376,507.462,512.052,514.644,517.731,521.817,528.909,532.905" svgx:width="0.5,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.25,0.55,0.5,0.28,0.39,0.44,0.5,0.5,0.28,0.28,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.5,0.28,0.5,0.25,0.55,0.44,0.5,0.78,0.5,0.28,0.44,0.28,0.5,0.44,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.44,0.5,0.28,0.33,0.44,0.78,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">natalizumab discontinuation and only complained of extreme </text>
   <text y="527.071" x="297.258,300.345,304.431,307.023,309.615,314.205,318.795,322.881,325.131,326.283,330.369,334.959,339.549,341.799,342.951,349.539,353.625,356.217,360.807,365.397,367.989,370.239,371.391,373.983,378.573,382.164,385.755,388.095,390.345,391.497,397.59,400.677,404.763,407.355,411.945,414.195,415.347,423.438,429.531,432.618,434.868,436.02,440.106,442.698,444.948,446.1,448.692,453.282,455.874,459.465,461.715,462.867,467.457,472.047,474.639,479.229,481.821,484.071,485.223,489.813,494.403,496.995,501.585,503.835,504.987,508.578,513.168,517.758,524.346,528.432,532.932" svgx:width="0.33,0.44,0.28,0.28,0.5,0.5,0.44,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.72,0.44,0.28,0.5,0.5,0.28,0.25,0.55,0.28,0.5,0.39,0.39,0.25,0.25,0.55,0.67,0.33,0.44,0.28,0.5,0.25,0.55,0.89,0.67,0.33,0.25,0.55,0.44,0.28,0.25,0.55,0.28,0.5,0.28,0.39,0.25,0.55,0.5,0.5,0.28,0.5,0.28,0.25,0.55,0.5,0.5,0.28,0.5,0.25,0.55,0.39,0.5,0.5,0.72,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">fatigue and weight loss. Brain MRI at this point only showed </text>
   <text y="538.069" x="297.258,299.85,303.936,307.527,310.119,314.709,319.299,322.89,324.825,328.911,333.501,340.593,345.183,349.269,351.861,354.453,359.043,361.635,365.721,367.656,374.244,376.836,379.428,384.018,385.953,394.044,399.138,401.478,403.251,408.84,413.43,416.517,420.603,424.689,426.624,430.71,435.3,439.89,441.825,445.911,447.846,452.436,456.522,459.114,462.201,464.136,471.228,475.818,480.408,483.0,487.59,491.181,493.116,497.202,500.289,502.881,506.967,510.054,511.989,516.579,520.665,523.257,527.343,529.935" svgx:width="0.28,0.44,0.39,0.28,0.5,0.5,0.39,0.25,0.44,0.5,0.78,0.5,0.44,0.28,0.28,0.5,0.28,0.44,0.25,0.72,0.28,0.28,0.5,0.25,0.89,0.56,0.25,0.25,0.61,0.5,0.33,0.44,0.44,0.25,0.44,0.5,0.5,0.25,0.44,0.25,0.5,0.44,0.28,0.33,0.25,0.78,0.5,0.5,0.28,0.5,0.39,0.25,0.44,0.33,0.28,0.44,0.33,0.25,0.5,0.44,0.28,0.44,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">lesions compatible with MS. Three and a half months after natal-</text>
   <text y="549.067" x="297.258,299.85,303.936,308.526,315.618,319.704,324.294,326.544,327.246,331.836,334.428,338.019,342.105,346.695,351.285,353.877,356.469,361.059,365.649,369.735,372.327,374.919,379.509,384.099,386.349,387.051,389.643,394.233,398.319,400.569,401.271,405.861,409.947,412.539,415.131,419.217,423.807,426.399,428.649,429.351,433.437,438.027,442.617,445.209,449.799,452.391,454.983,459.069,463.659,465.909,466.611,473.703,477.789,480.876,485.466,489.552,494.142,496.392,497.094,501.684,505.77,508.362,512.448,515.535,518.127,522.717,525.804,529.89" svgx:width="0.28,0.44,0.5,0.78,0.44,0.5,0.25,0.55,0.5,0.28,0.39,0.44,0.5,0.5,0.28,0.28,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.25,0.55,0.44,0.5,0.5,0.28,0.5,0.28,0.28,0.44,0.5,0.25,0.55,0.78,0.44,0.33,0.5,0.44,0.5,0.25,0.55,0.5,0.44,0.28,0.44,0.33,0.28,0.5,0.33,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">izumab discontinuation the patient exhibited marked deteriora-</text>
   <text y="560.065" x="297.258,299.85,302.442,307.032,311.622,314.25,320.838,323.43,326.022,330.612,333.24,337.83,342.42,349.512,352.104,354.696,357.288,361.878,366.468,368.808,371.436,376.026,380.112,383.199,385.791,388.383,392.973,397.563,399.903,402.531,407.121,411.711,414.798,417.39,421.476,426.066,430.656,433.248,437.334,439.926,442.554,447.144,451.734,455.325,457.917,462.003,466.593,473.685,478.275,481.866,484.494,488.58,493.17,497.76,500.388,504.474,507.066,511.152,515.742,518.334,522.42,524.76,526.893,532.896" svgx:width="0.28,0.28,0.5,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.5,0.5,0.78,0.28,0.28,0.28,0.5,0.5,0.25,0.25,0.5,0.44,0.33,0.28,0.28,0.5,0.5,0.25,0.25,0.5,0.5,0.33,0.28,0.44,0.5,0.5,0.28,0.44,0.28,0.25,0.5,0.5,0.39,0.28,0.44,0.5,0.78,0.5,0.39,0.25,0.44,0.5,0.5,0.25,0.44,0.28,0.44,0.5,0.28,0.44,0.25,0.25,0.72,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tion with vomiting, vertigo, horizontal nystagmus and ataxia. A </text>
   <text y="571.063" x="297.258,300.345,304.431,309.021,313.107,317.193,319.785,322.692,327.282,330.369,334.455,337.047,341.637,344.553,352.644,358.737,361.824,364.74,368.331,372.921,377.511,384.099,388.185,392.775,395.682,399.768,402.684,407.274,411.864,416.454,419.541,423.627,428.217,432.807,436.893,441.483,445.569,448.161,452.751,457.341,460.257,462.849,466.935,470.526,473.118,477.708,482.298,485.214,487.806,492.396,495.303,499.893,504.483,507.075,511.665,514.572,518.658,522.744,525.831,529.917" svgx:width="0.33,0.44,0.5,0.44,0.44,0.28,0.25,0.5,0.33,0.44,0.28,0.5,0.25,0.89,0.67,0.33,0.25,0.39,0.5,0.5,0.72,0.44,0.5,0.25,0.44,0.25,0.5,0.5,0.5,0.33,0.44,0.5,0.5,0.44,0.5,0.44,0.28,0.5,0.5,0.25,0.28,0.44,0.39,0.28,0.5,0.5,0.25,0.28,0.5,0.25,0.5,0.5,0.28,0.5,0.25,0.44,0.44,0.33,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">repeat brain MRI showed a non-enhancing lesion in both cere-</text>
   <text y="582.061" x="297.258,301.848,305.934,308.526,311.118,315.204,318.291,320.541,323.772,328.362,332.448,337.038,341.628,346.218,350.808,354.894,357.486,361.572,365.163,367.413,370.644,374.73,379.32,386.412,391.002,395.088,397.68,400.272,404.862,407.454,411.54,413.79,417.021,423.609,426.201,428.793,433.383,435.633,438.864,443.958,452.049,457.305,459.555,462.786,466.872,471.462,476.052,478.302,481.533,487.626,492.72,497.814,500.064,503.295,507.381,511.971,516.057,518.649,523.239,526.83,529.422,532.923" svgx:width="0.5,0.44,0.28,0.28,0.44,0.33,0.25,0.55,0.5,0.44,0.5,0.5,0.5,0.5,0.44,0.28,0.44,0.39,0.25,0.55,0.44,0.5,0.78,0.5,0.44,0.28,0.28,0.5,0.28,0.44,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.56,0.89,0.61,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.67,0.56,0.56,0.25,0.55,0.44,0.5,0.44,0.28,0.5,0.39,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">bellar penduncles compatible with PML and CSF analysis </text>
   <text y="593.059" x="297.258,300.849,305.439,310.029,316.617,320.703,325.293,327.633,332.223,336.813,341.403,343.743,347.334,353.427,359.853,362.193,366.279,370.869,375.459,378.051,382.137,385.728" svgx:width="0.39,0.5,0.5,0.72,0.44,0.5,0.25,0.5,0.5,0.5,0.25,0.39,0.67,0.72,0.25,0.44,0.5,0.5,0.28,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">showed 150 JCV copies.</text>
   <text y="604.057" x="297.258,303.756,307.752,311.253,316.257,318.759,321.756,325.257,328.254" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="604.057" x="331.962,337.461,341.961,345.957,348.207,349.665,354.165,358.161,360.663,363.165,367.161,371.661,374.163,376.413,377.871,380.868,384.864,388.86,392.856,395.358,399.858,403.854,408.354,410.604,412.062,416.562,419.064,423.564,428.064,430.314,431.772,436.272,440.772,444.273,448.269,450.519,451.977,456.477,459.474,461.724,463.182,467.178,471.678,474.675,477.177,479.679,483.675,488.175,491.676,494.178,498.174,501.171,505.671,508.173,512.673,516.174,518.424,519.882,523.878,528.378,532.878" svgx:width="0.61,0.5,0.44,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.25,0.55,0.33,0.44,0.44,0.44,0.28,0.5,0.44,0.5,0.25,0.55,0.5,0.28,0.5,0.5,0.25,0.55,0.5,0.5,0.39,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.44,0.5,0.33,0.28,0.28,0.44,0.5,0.39,0.28,0.44,0.33,0.5,0.28,0.5,0.39,0.25,0.55,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">The patient received high dose of corticosteroids and </text>
   <text y="615.055" x="297.258,300.255,306.753,309.75,316.248,318.498,320.109,326.607,329.109,331.611,336.111,338.361,339.972,342.474,346.974,349.476,351.978,354.48,358.476,360.978,363.228,364.839,367.341,374.343,378.843,381.84,386.34,390.84,394.836,401.838,405.834,410.334,412.836,415.086,416.697,421.197,425.697,428.199,430.449,432.06,436.56,440.556,443.058,447.054,450.051,452.553,457.053,460.05,464.046,466.548,469.05,473.55,478.05,480.3,481.911,484.413,488.409,490.911,494.907,497.904,500.154,501.765,506.265,510.765,513.015,515.265,516.876,521.376,525.876,528.378,532.878" svgx:width="0.33,0.72,0.33,0.72,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.28,0.5,0.28,0.28,0.28,0.44,0.28,0.25,0.55,0.28,0.78,0.5,0.33,0.5,0.5,0.44,0.78,0.44,0.5,0.28,0.25,0.55,0.5,0.5,0.28,0.25,0.55,0.5,0.44,0.28,0.44,0.33,0.28,0.5,0.33,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.28,0.44,0.28,0.44,0.33,0.25,0.55,0.5,0.5,0.25,0.25,0.55,0.5,0.5,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">IVIG with initial improvement but deterioration later on, both </text>
   <text y="626.053" x="297.258,301.254,303.756,306.258,310.758,313.26,317.256,321.252,323.754,326.256,330.756,333.006,333.708,337.704,342.204,346.704,348.954,349.656,354.156,358.656,360.906,361.608,364.11,368.61,372.606,374.856,375.558,383.559,389.562,392.559,394.809,397.059,397.761,400.758,404.259,408.759,411.756,415.752,419.748,424.248,426.75,431.25,435.75,438.0,438.702,443.202,446.199,448.449,449.151,451.653,456.153,460.149,462.399,463.101,465.603,469.599,473.1,475.602,480.102,484.602,486.852,487.554,490.056,494.556,496.806,497.508,500.01,504.51,508.506,510.756,511.458,515.958,518.955,522.951,525.453,529.953" svgx:width="0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.28,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.89,0.67,0.33,0.25,0.25,0.55,0.33,0.39,0.5,0.33,0.44,0.44,0.5,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.28,0.44,0.39,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.33,0.44,0.28,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">clinically and on the MRI, (spreading of the lesion in the brain-</text>
   <text y="637.051" x="297.258,300.759,303.261,307.257,314.259,317.256,319.506,321.864,327.363,331.863,335.859,338.379,342.879,346.875,349.377,351.879,355.875,360.375,362.877,365.397,368.394,372.39,376.386,380.382,382.884,387.384,391.38,395.88,398.4,401.397,405.897,408.894,411.396,415.896,419.892,422.889,425.409,429.405,433.905,436.902,439.404,441.906,445.902,450.402,453.903,456.405,460.401,463.398,467.898,470.4,474.9,477.42,479.922,482.919,486.915,490.911,493.413,500.415,504.411,508.911,511.413,513.933,516.93,521.43,525.93,528.432,532.932" svgx:width="0.39,0.28,0.44,0.78,0.33,0.25,0.25,0.61,0.5,0.44,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.25,0.33,0.44,0.44,0.44,0.28,0.5,0.44,0.5,0.25,0.33,0.5,0.33,0.28,0.5,0.44,0.33,0.25,0.44,0.5,0.33,0.28,0.28,0.44,0.5,0.39,0.28,0.44,0.33,0.5,0.28,0.5,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.33,0.5,0.5,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">stem). The patient received further corticosteroid treatment (both </text>
   <text y="648.049" x="297.258,300.255,306.591,308.571,312.567,317.067,321.567,323.547,328.047,332.043,335.04,337.02,341.52,345.021,348.018,349.998,353.994,357.495,359.475,365.973,369.969,372.471,374.973,376.953,380.949,384.45,386.43,388.932,395.934,402.936,407.436,411.936,416.436,423.438,427.938,432.438,436.938,439.44,443.436,445.938,450.438,453.435,457.935,459.915,462.417,465.414,469.41,473.406,475.908,482.91,486.906,491.406,493.908,495.888,502.386,504.888,507.39,511.89,513.87,518.37,520.872,524.868,527.37,529.872" svgx:width="0.33,0.72,0.25,0.44,0.5,0.5,0.25,0.5,0.44,0.33,0.25,0.5,0.39,0.33,0.25,0.44,0.39,0.25,0.72,0.44,0.28,0.28,0.25,0.44,0.39,0.25,0.28,0.78,0.78,0.5,0.5,0.5,0.78,0.5,0.5,0.5,0.28,0.44,0.28,0.5,0.33,0.5,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.72,0.28,0.28,0.5,0.25,0.5,0.28,0.44,0.28,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">IV and per os) as well as immunomodulatory treatment with glati-</text>
   <text y="659.047" x="297.258,300.255,304.251,311.253,315.249,318.246,320.487,324.483,328.479,332.475,334.977,338.973,341.475,345.471,347.712,351.708,356.208,360.708,362.949,366.945,371.445,375.945,378.942,383.442,387.942,390.444,397.446,401.442,403.944,407.94,410.442,414.942,417.183,421.683,423.924,430.926,435.426,439.926,442.428,446.928,450.429,452.67,455.172,459.168,461.67,465.666,468.663,470.904,475.404,479.4,482.397,484.638,488.634,493.134,497.634,502.134,504.636,507.138,509.64,514.14,518.64,520.881,525.381,529.377,532.878" svgx:width="0.33,0.44,0.78,0.44,0.33,0.25,0.44,0.44,0.44,0.28,0.44,0.28,0.44,0.25,0.44,0.5,0.5,0.25,0.44,0.5,0.5,0.33,0.5,0.5,0.28,0.78,0.44,0.28,0.44,0.28,0.5,0.25,0.5,0.25,0.78,0.5,0.5,0.28,0.5,0.39,0.25,0.28,0.44,0.28,0.44,0.33,0.25,0.5,0.44,0.33,0.25,0.44,0.5,0.5,0.5,0.28,0.28,0.28,0.5,0.5,0.25,0.5,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ramer acetate and approximately 8 months later her condition has </text>
   <text y="670.045" x="297.258,300.759,303.261,307.257,311.757,314.259,316.761,319.263,323.259,327.255,331.755,334.005,338.487,344.985,347.487,349.989,354.489,356.739,361.221,368.223,372.723,377.223,381.219,384.216,388.212,390.714,394.71,396.96,401.442,403.944,410.946,415.446,418.443,422.943,427.443,431.439,438.441,442.437,446.937,449.439,451.689,456.171,459.168,464.667,471.165,476.169,481.173,483.675,485.925,490.407,494.907,497.904,500.154,502.404,506.886,511.89,514.392,518.388,521.889,528.891,532.887" svgx:width="0.39,0.28,0.44,0.5,0.28,0.28,0.28,0.44,0.44,0.5,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.78,0.5,0.5,0.44,0.33,0.44,0.28,0.44,0.25,0.55,0.28,0.78,0.5,0.33,0.5,0.5,0.44,0.78,0.44,0.5,0.28,0.25,0.55,0.33,0.61,0.72,0.56,0.56,0.28,0.25,0.55,0.5,0.33,0.25,0.25,0.55,0.56,0.28,0.44,0.39,0.78,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">stabilized with moderate improvement (EDSS: 7). Plasma </text>
   <text y="681.043" x="297.258,301.254,305.754,309.75,314.25,318.246,322.746,327.246,331.242,334.113,340.611,344.607,348.108,350.979,355.479,359.979,362.481,365.352,369.348,376.35,380.85,383.352,387.852,392.352,396.348,400.848,403.719,407.715,411.216,414.087,416.589,421.089,425.085,427.956,432.456,435.453,439.953,444.453,447.324,453.822,457.818,461.319,464.19,468.186,472.686,477.186,480.687,483.189,487.689,491.685,494.682,498.678,503.178,506.049,508.551,513.051,515.922,520.422,524.418,528.918,532.914" svgx:width="0.44,0.5,0.44,0.5,0.44,0.5,0.5,0.44,0.25,0.72,0.44,0.39,0.25,0.5,0.5,0.28,0.25,0.44,0.78,0.5,0.28,0.5,0.5,0.44,0.5,0.25,0.44,0.39,0.25,0.28,0.5,0.44,0.25,0.5,0.33,0.5,0.5,0.25,0.72,0.44,0.39,0.25,0.44,0.5,0.5,0.39,0.28,0.5,0.44,0.33,0.44,0.5,0.25,0.28,0.5,0.25,0.5,0.44,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">exchange was not employed as the drug was considered to have </text>
   <text y="692.041" x="297.258,301.758,305.754,309.75,314.25,316.5,317.877,321.873,324.375,326.877,333.879,336.381,340.881,344.877,347.379,351.375,355.875,358.125,359.502,362.499,365.496,369.996,376.998,379.248,380.625,383.127,387.627,391.623,393.873,395.25,399.75,403.746,406.248,408.75,412.746,417.246,419.748,422.25,425.751,428.001,429.378,433.878,438.378,442.878,446.793,449.043,451.293,452.67,458.673,462.669,467.169,471.165,475.161,477.663,479.913,481.29,489.291,495.294,498.291,501.792,504.042,505.419,508.92,513.42,517.92,524.418,528.414,532.914" svgx:width="0.5,0.44,0.44,0.5,0.25,0.55,0.44,0.28,0.28,0.78,0.28,0.5,0.44,0.28,0.44,0.5,0.25,0.55,0.33,0.33,0.5,0.78,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.33,0.39,0.25,0.55,0.5,0.5,0.5,0.5,0.25,0.25,0.55,0.67,0.44,0.5,0.44,0.44,0.28,0.25,0.55,0.89,0.67,0.33,0.39,0.25,0.55,0.39,0.5,0.5,0.72,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">been eliminated from the patientâ€™s body. Repeat MRIs showed </text>
   <text y="703.039" x="297.258,301.758,304.755,308.751,313.251,317.751,321.747,324.249,326.499,328.065,330.567,337.569,342.069,345.066,349.566,354.066,358.062,365.064,369.06,373.56,376.062,378.312,379.878,384.378,387.375,389.625,391.191,393.693,398.193,402.189,404.439,406.005,408.507,412.503,416.004,418.506,423.006,427.506,429.756,431.322,435.318,439.818,444.318,446.568,448.134,452.13,454.632,456.882,458.448,462.948,467.448,469.698,471.264,475.764,480.264,482.766,487.266,489.768,492.018,493.584,500.082,504.078,507.579,509.829,511.395,513.897,517.893,521.394,523.896,528.396,532.896" svgx:width="0.5,0.33,0.44,0.5,0.5,0.44,0.28,0.25,0.55,0.28,0.78,0.5,0.33,0.5,0.5,0.44,0.78,0.44,0.5,0.28,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.28,0.44,0.39,0.28,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.44,0.28,0.25,0.55,0.5,0.5,0.25,0.55,0.5,0.5,0.28,0.5,0.28,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.28,0.44,0.39,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">gradual improvement of the lesion and at no point was lesion </text>
   <text y="714.037" x="297.258,301.254,305.754,310.254,314.25,318.75,322.746,326.742,333.744,337.74,342.24,344.742,346.992,349.413,353.913,357.909,360.411,364.407,368.403,370.905,374.901,379.401,381.651,384.072,390.57,395.07,397.572,401.568,406.068,408.318,410.739,417.237,421.737,426.237,428.739,433.239,435.489,437.91,442.41,446.406,448.656,451.077,453.579,458.079,462.579,465.081,469.077,473.073,475.575,478.077,482.577,486.573,488.823,491.244,495.744,498.741,500.991,503.412,505.914,512.916,519.918,524.418,528.918,532.914" svgx:width="0.44,0.5,0.5,0.44,0.5,0.44,0.44,0.78,0.44,0.5,0.28,0.25,0.55,0.5,0.44,0.28,0.44,0.44,0.28,0.44,0.5,0.25,0.55,0.72,0.5,0.28,0.44,0.5,0.25,0.55,0.72,0.5,0.5,0.28,0.5,0.25,0.55,0.5,0.44,0.25,0.55,0.28,0.5,0.5,0.28,0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.78,0.78,0.5,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">enhancement detected which would be indicative of immune </text>
   <text y="725.035" x="297.258,300.255,304.251,308.247,312.747,317.247,320.748,323.25,325.752,328.254,332.754,335.256,337.758,342.258,346.758,349.008,351.51,356.01,359.007,361.509,365.505,372.507,379.509,383.505,386.007,390.507,393.504,398.004,400.254,403.755,408.255,412.755,417.255,420.252,424.752,431.754,435.75,438.0,440.997,443.994,449.997,452.994,457.998,460.995" svgx:width="0.33,0.44,0.44,0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.28,0.28,0.5,0.5,0.25,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.39,0.5,0.5,0.5,0.33,0.5,0.78,0.44,0.25,0.33,0.33,0.67,0.33,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">reconstitution inflammatory syndrome (IRIS).</text>
  </g>
 </g>
</svg>
